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Ionic liquids (ILs) are organic salts that melt at or below 100°C. Interest in ILs continues 
to grow due to their unique properties such as lack of measurable vapor pressure, high thermal 
stability, tunability and recyclability. The first part of this dissertation explores the use of chiral 
ionic liquids (CILs) for enantiomeric recognition of chiral analytes using fluorescence 
spectroscopy. Chiral analyses continue to be a subject of considerable interest primarily as a 
result of legislation introduced by the Food and Drug Administration. This has led to an 
increased need for suitable chiral selectors and methods to verify the enantiomeric forms of 
drugs. In this study, CILs derived from amino acid esters were used simultaneously as solvents 
and chiral selectors for enantiomeric recognition of various fluorescent as well as non-
fluorescent chiral analytes.  
The second part of this dissertation focuses on the development of a new class of 
fluorescent near infrared (NIR) nanoparticles from a Group of Uniform Materials Based on 
Organic Salts (GUMBOS) largely comprising frozen ILs. The GUMBOS were subsequently 
used to fabricate nanoGUMBOS using a reprecipitation method. The potential of the NIR 
nanoGUMBOS for non-invasive imaging was evaluated by fluorescence imaging of Vero cells 
incubated with nanoGUMBOS. Fluorescence imaging of diseased cells and tissues is useful for 
early detection and treatment of diseases. The work presented here is significant and may 
improve the quality of human life by employing NIR nanoGUMBOS as contrast agents for early 
diagnosis and treatment of some diseases. Through variations in the anion, different spectral 





1.1. Ionic Liquids (ILs)   
ILs are defined as organic salts with a melting point at or below 100 ºC.
1, 2
 Although ILs 
received increased attention recently, they have been known since 1914 when Paul Walden 
discovered ethylammonium nitrate with a melting point of 12 ºC, which is now regarded as the 
first ionic liquid.
3
 An arbitrary temperature limit of 100 °C has been used to distinguish ILs from 
inorganic molten salts which generally have high melting points.
4
 The low melting point of ILs 
has been attributed to asymmetry of the component cations and anions leading to frustrated 
crystal packing.
5, 6
 The effect of cation symmetry is further illustrated by the higher melting 
points reported for ILs containing symmetrical 1,3-dimethylimidazolium and 1,3- 
diethylimidazolium salts compared to the more unsymmetrical 1-ethyl-3-methylimidazolium or 
1-butyl-3- methylimidazolium cations.
7
 It has also been reported by Holbrey et al. that crystal 




One of the widely used method in the synthesis of ILs is anion metathesis between a 
halide salt and the metal (or ammonium) salt of the desired anion. This results in ILs with cations 
such as imidazolium, ammonium, pyridinium, and phosphonium cations. Examples  of 
commonly used anions include bis (trifluoromethyl) sulfonimide, hexafluorophosphate, 
tetrafluoroborate and nitrate.
9
 Another method that results in ILs is the acid-base neutralization 
reaction followed by removal of water in vacuo. Indeed the first ionic liquid reported, ethyl 
ammonium nitrate, was prepared using the acid-base neutralization reaction between ethylamine 
and nitric acid.
3
 Various ILs containing amino acid anions and tetrabutylammonium or 




 Direct combination of a halide salt with a metal halide is another approach that 
affords ILs. This approach is illustrated by the first preparation of the magnetic ionic liquid 
[bmim] [FeCl4] by mixing equimolar amounts of [bmim] [Cl] and FeCl3.
11
 A further example of 
direct combination is the synthesis of a series of transition metal based magnetic ILs by Del 
Sesto and coworkers.
12




Interest in ILs stems from their unique properties such as negligible vapor pressure, high 
thermal stability, high ionic conductivity, high solubility for various compounds (polar/non-
polar, organic/inorganic), and recyclability.
9
 In addition, ILs are easily tunable by careful choice 
of cation or anion. The lack of measurable vapor pressure and high thermal stability of ILs has 
been attributed to large cohesive energy density provided by Coulombic interactions between the 
constituent ions.
13
 After being latent for sometime, research activity in room temperature ionic 
liquids (RTILs) was renewed with the discovery of alkylpyridinium and 1,3-dialkylimidazolium 
haloaluminate salts.
14
 In 1975, the first electrochemical study on these new liquid salts such as 
[ethylpryidinium bromide]-[AlCl3] was reported.
15
 The Lewis acidity of these ILs could be tuned 
by varying the molar ratio of the two ionic components. However, these haloaluminate ionic 
liquids are extremely sensitive to hydrolysis by atmospheric moisture and require handling 
strictly under anhydrous conditions. This problem was alleviated with the discovery of 
imidazolium ILs containing tetrafluoroborate and hexafluorophosphate anions that do not impose 
such special handling requirements.
16, 17
 However, it has been reported that hexafluorophosphate 
ionic liquids releases HF in the presence of moisture and may not be suitable for electrochemical 
applications.
18
 Overall, there are approximately 10
18
 possible combinations of various cations 




of some cations and anions commonly used to prepare ILs are shown (Scheme 1.1).
20, 21
 Such ILs 




Scheme 1.1. Representative common cations and anions used in the synthesis of ILs. (Adapted 
from reference 18).  
 
Over the last two decades, there has been tremendous interest in ILs research as reflected 
by the steeper than exponential growth in the number of publications and patents (Figure 1.1).
18
 
The ability to tailor the properties of ILs for specific applications has led to preparation of 
various novel ILs generally known as task specific ionic liquids (TSILs). An example of TSILs is 
chiral ionic liquids (CILs)
22
 and their use in spectroscopic chiral discrimination will be described 
later in this dissertation.  Novel functionalized TSILs for metal extraction have also been 
reported.
23, 24
 Other examples of TSILs include magnetic ILs
11, 12
 and protic ILs.
25






Figure 1.1. Annual growth of ionic liquid (A) publications from 1986-2009, and (B) patents 















 and energy storage.
32
 ILs have also been used as alternatives to 









In addition, ILs have proven to be useful in chromatography as buffers 
in capillary electrophoresis (CE),
37
 stationary phases in gas chromatography (GC)
38, 39
 and high 
performance liquid chromatography (HPLC).
40




In the past, ILs was a matter of academic curiosity but are now finding their way into industry. 
Some industrial applications of ILs such as their uses in solar panels, batteries, fuel cells, 
lubricants, drug delivery, catalysis, and gas chromatography have been extensively reviewed.
18
 
Interesting novel uses are being made of the unique physical properties of ILs including sending 
them to the moon. Borra et al. have proposed the deposition of metal films on an ionic liquid for 
use in space telescopes.
42
 According to Borra and coworkers, this is possible because the non 
volatile nature of ILs enables their use under the lunar vacuum conditions. In addition, handling 
of ILs in space is a lot easier since they are less dense compared to the currently used mercury.
42
 
The future of ILs looks even brighter since an extrapolation of their potential uses extends to 
almost every possible industrial application process (Figure 1.2).
18
 This dissertation focuses on 
the use of CILs for enantiomeric recognition of chiral analytes using spectroscopy. 
1.2. Chiral Ionic Liquids (CILs) 
CILs are a subclass of ILs in which the cation or the anion (or both) may be chiral. During the 
synthesis of the N-heterocyclic carbene complexes based on imidazolium precursors, Herrmann 
and coworkers
43
 prepared two chiral imidazolium chloride salts as synthesis intermediates. 
However, during this time, the two chiral imidazolium chloride salts were not referred to as CILs 
in Hermann‟s work.
43
  Generally, CILs are a recent development as compared to achiral ILs. To  
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Figure 1.2. Prediction of the future commercial uses of ILs in various fields (adapted  
from reference 18). 
 
our knowledge, Howarth et al. synthesized the first example of a CIL in 1997 with a chiral 
dialkylimidazolium cation, N,N-bis[(2S)-2-methylbutyl]imidazolium bromide, 1 (Scheme 1.2).
22
 
This moisture stable imidazolium bromide salt was used as the Lewis acid catalyst in the Diels-
Alder reaction.
22
  In 1999, Seddon and coworkers reported the first synthesis of CIL containing 
chiral anion, 1-butyl-3-methyl imidazolium lactate, 2 (Scheme 1.2).
44
 To our knowledge, CILs in 
which both ions are chiral were rare until Machado and Dorta reported the first “doubly chiral” 
ILs containing imidazolium cations and anions derived from camphor, tartaric acid and β-
pinene.
45
 Another example of CIL containing both chiral cation and anion, L-alanine butyl ester 
lactate, 3, has been reported by the Warner group (Scheme 1.2).
46
 Most of the CILs that have 












Scheme 1.2. Structural examples of CILs containing chiral: cation (1), anion (2) cation and anion 
(3). 
 
Since the discovery of CILs, there have been extensive studies on their synthesis and 
applications. The most commonly used methods in the synthesis of CILs are anion metathesis
46
 
and acid-base neutralization reactions.
10
 Details of the synthesis and applications of various CILs 
are provided in several outstanding reviews.
49-55
 More interestingly, CILs can be designed and 
tailored to specific applications by simply changing the cation, anion or their combination. The 
tunability of CILs is one of the unique and highly desirable properties of ILs. The applications of 
CILs may be categorized into asymmetric synthesis and catalysis, enantiomeric chromatographic 
separation, and chiral spectroscopic discrimination.
56
 Although the the focus of this dissertation 
is on the use of CILs for enantiomeric recognition using nuclear magnetic resonance (NMR) and 
fluorescence spectroscopy, the various applications of CILs will be discussed briefly in the 
following section.  
3 
 8 
1.2.1. Applications of Chiral Ionic Liquids  
1.2.1.1. CILs in Asymmetric Catalysis and Synthesis  
As noted earlier, CILs have been used for various applications. In contrast to regular organic 
solvents, CILs can serve as chiral solvents and catalysts. Moreover, the relatively simple 
synthesis of CILs from the readily available chiral starting materials such as amino acids and the 
possibility of recycling CILs (due to their non-volatility) make them promising new chiral 
solvents in asymmetric catalysis and synthesis. Thus CILs have been used as chiral solvents and 







, and Michael addition.
60
 The application of CILs in asymmetric synthesis and catalysis 
have been extensively reviewed.
52, 53, 55
  
1.2.1.2. CILs in Enantiomeric Chromatographic Separation 
The three common methods for enantiomeric separation include gas chromatography (GC), 
capillary electrophoresis (CE) including micellar electrokinetic chromatography (MEKC), and 
high performance liquid chromatography (HPLC). CILs can be used for chromatographic 
separations due to their properties such as high thermal stability and ionic conductivity.  
1.2.1.2.1. CILs in GC Separation 
The low vapor pressure and high thermal stability of CILs render them suitable for 
enantioseparations in gas chromatography (GC). Recently, CILs have been used as chiral 
stationary phases in GC.
61
 Armstrong and coworkers carried out enantiomeric separation of 
chiral alcohols and diols, chiral sulfoxides, some chiral epoxides and acetamides using a CIL 
based on ephedrinium salt. Another example is the use of the CIL, (R)-N,N,N-trimethyl-2-






1.2.1.2.2. CILs in CE and MEKC Separation 
The conductivity of ILs offers the possibility of using them as electrolytes in CE. 
Enantiomeric separation using CILs in CE is often a desirable alternative, especially when there 
is a trace amount of sample available and short analysis time is required. Yuan and coworkers 
found that the CIL, (R)-N,N,N-trimethyl-2-aminobutanol bis(trifluoromethylsulfonyl)imide, is a 
good chiral selector that could be used in CE for enantioseparation of various compounds such as 
propranolol.
62
 Recently, Tran and Mejac demonstrated the separation of various pharmaceutical 
products using a CIL, S-[3-(chloro-2-hydroxypropyl) trimethylammonium] 
[bis(trifluoromethylsulfonyl)imide,], as co-electrolyte and chiral selector in the presence of 
additives such as sodium cholate.
63
 The chiral buffer was also capable of enantiomeric 
recognition of iburprofen. It is worth noting that no resolution was achieved when additives were 




Two CILs [(ethyl and phenyl choline cations with bis (trifluoromethylsulfonyl) imide) anion] 
have been evaluated by Francois et al. as chiral selectors for enantiomeric separation of 
arylpropionic acids by CE.
64
 No direct enantioselectivity was observed for these two CILs, 
except in the presence of β-cyclodextrins, suggesting that a synergistic effect of the two selectors 
is responsible for increased resolution and separation efficiency. Tran and Mejac demonstrated 
an influence of the β-cyclodextrin on the competition between the analyte and the IL cation with 
respect to β-cyclodextrin complexation. However, the presence of the phenyl group in the IL 
cation appeared to be less important in enhancing the synergistic effects. This indicates that 
specific ion-pairing interactions could be involved.
64
 Maier and coworkers synthesized a new 
CIL, [S-(−)-2-hydroxymethyl-1,1-dimethylpyrrolidinium tetrafluoroborate] derived from L-
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proline alcohol and found it to be an effective additive to acidic background electrolytes 
affording the separation of a mixture of five achiral tricyclic antidepressants using CE.
65
  
 The application of novel IL-type surfactants and their polymers for chiral separation of 






were derived from 
the monomers and polymers of undecenoxycarbonyl-L-leucinol bromide which is an IL at room 
temperature, and undecenoxy carbonyl- L-pyrolidinol bromide, that forms a greasy solid with a 
melting point of 30-35°C. Chiral separation was suggested to be strongly dependent on the 




1.2.1.2.3. CILs in HPLC Separation 
In liquid chromatography (LC), the low vapor pressure of CILs is not a crucial requirement. 
However, CILs may provide the desired selectivity and solubility for enantiomeric separations. 
The possibility of replacing organic solvents by ILs in LC is limited by their rather high 
viscosities. In addition, the use of ILs on silica stationary phases often produces interactions 
between IL cations and the anionic silanol stationary phase, which lead to peak tailing and longer 
retention times. To circumvent the aforementioned problems, CILs may be used as additives or 
silanol blocking agents may be used to afford enantiomeric separation.
67
 The CIL, (R)-N,N,N-
trimethyl-2-aminobutanol-bis (trifluoromethanesulfon) imidate, has also been used in HPLC for 
enantioseparation of compounds such as alcohols, amines, and amino acids.
62
  
1.2.1.3. Applications of Chiral Ionic Liquids in Enantiomeric Spectroscopic Discrimination 
 
In contrast to chromatographic methods, there is no “real” separation of enantiomers 
using spectroscopic techniques for chiral discrimination. Interestingly, chiral spectroscopic 
techniques are very useful in chiral technology for rapid and accurate determination of the 
enantiopurity of chiral compounds. In addition, spectroscopy may provide important information 
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regarding the structure-property relationship and mechanism of chiral interaction and 
recognition. Recently, CILs have been used as the chiral selectors in spectroscopic techniques 
such as nuclear magnetic resonance (NMR), fluorescence, and near infrared (NIR). In this 
dissertation, NMR and fluorescence spectroscopy were used for enantiomeric recognition 
studies.  
1.2.1.3.1. Chiral Discrimination Using CILs in NMR Spectroscopy 
One of the most common methods employed for analyses of chiral compounds is NMR 
spectroscopy.
68, 69
 In NMR, nuclei can be classified as isochronous or anisochronous. Where 
diastereotopic protons show the same chemical shift, they are said to be equivalent or 
isochronous, and where they have different chemical shifts, the protons are described as 
anisochronous. Enantiomers cannot be discriminated in an achiral medium because the 
resonances of enantiotopic nuclei are isochronous. However, diastereoisomers may be 
distinguished as the resonances are anisochronous. As long as there is a large enough 
nonequivalent chemical shift to give baseline resolution of the appropriate signals, then 
integration gives a direct measure of enantiomeric composition.
70
  
Recently, CILs have been widely used as the chiral solvating agents in NMR studies. In 
these applications, CILs can be dissolved in deuterated NMR solvents and used as the chiral 
solvating agent. They can form diastereomeric associates in situ with substrate enantiomers via 
rapidly reversible equilibriums in competition with the bulk solvent. This method is quick and 
simple to perform with no problems of kinetic resolution or sample racemization which may 
occur when chiral derivatizing agents are used. Nonpolar solvents such as deuterated chloroform, 
benzene, and carbon tetrachloride tend to maximize the observed anisochrony between the 
diastereoisomeric complexes whereas the more polar solvents such as deuterated acetonitrile, 




Most chiral discrimination studies of CILs in NMR have been carried out using Mosher‟s 
acid (α-methoxy-α-(trifluoromethyl)phenylacetic acid).
71
 Mosher‟s acid was first introduced as a 
chiral derivatizing agent by Mosher in 1969.
71, 72
 The absence of α-hydrogen in the carboxylic 
group of Mosher‟s acid alleviates the problem of racemization during the derivatization. It is 
now commercially available in enantiopure form, either as the acid or acid chloride. In addition, 
both the 
1
H NMR and 
19
F NMR can be employed to investigate the diastereomeric interactions 
since Mosher‟s acid contains both hydrogen and fluorine nuclei. The enantiomeric recognition of 
the CILs described in this dissertation was investigated using Mosher‟s sodium salt.  
 To our knowledge, the first example of 
19
F NMR investigation of CILs was reported in 
2002 by Wasserscheid and co-workers using chiral cations derived directly from the chiral 
pool.
73
 The diastereomeric interactions between a racemic mixture of sodium Mosher‟s salt as 
substrate and the ephedrine-based CIL, as the chiral selector was investigated using 
19
F NMR 
spectroscopy. The splitting of the racemic Mosher‟s salt signal using 
19
F NMR clearly indicates 
















F NMR of racemic sodium Mosher‟s salt in presence of ephredrinium CIL. 




The extent of peak splitting can be assigned to the strength of the diastereomeric 
interactions. In other words, under identical experimental conditions, the greater splitting 
indicates stronger chiral discrimination abilities of the CILs used as chiral selectors. It is also 
noteworthy that the chemical shift difference for the two diastereomeric CF3-groups largely 
depends on the concentration of the CILs in the deuterated solvent. Generally, the higher the 
concentration of CIL, the greater the splitting of of the CF3 signal in 
19
F NMR. It has also been 




We note that the increase in the extent of peak splitting in presence of added water is 
dependent on the analyte used. For instance, Guillemin and coworkers while investigating 
enantiomeric discrimination using valine based CILs found that addition of water to the NMR 
solvent diminished the chemical shift difference.
74
 This is contradictory to the previous findings 
by Wasserscheid in which the addition of water was found to significantly increase the extent of 
splitting of the CF3 signals.
73
 The decreased chemical shift difference was attributed to breaking 
of hydrogen bonds responsible for diastereomeric interaction by the water molecules. These 
findings suggest that water plays different roles in chiral discrimination depending on the chiral 
interaction mechanism between the CILs and the chiral analytes. 
After the pioneering work by Wasserscheid, a wide variety of CILs have been investigated for 
their chiral recognition ability using 
19
















, and spiral borates.
81
 
 1.2.1.3.2. Chiral Discrimination Using CILs in Fluorescence Spectroscopy 
Fluorescence is a spectroscopic technique which has been widely used to study molecular 
interactions such as in biological systems.
82
 It is also a useful tool for the study of chiral 
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interaction and discrimination. It can provide useful information about molecular interactions 
with high sensitivity. The application of fluorescence to specifically study enantioselective 
interactions and chiral recognition has been reported.
83-85
 Most of these fluorescence studies 
involve the measurements of fluorescence emission intensities, spectral shifts and quenching 
effects. 
Steady state fluorescence spectroscopy has been successfully employed for enantiomeric 
discrimination of chiral molecules of pharmaceutical products. The emission spectral properties 
of enantiomers of a chiral molecule are identical in a non-chiral environment. In contrast, 
enantiomers of chiral molecules have significantly different spectral properties in a chiral 
environment as a result of induced diastereomeric complex formation with chiral selectors. 
Differences in the spectral properties of enantiomers in a chiral environment therefore permit the 
use of fluorescence spectroscopy for effective chiral discrimination of enantiomers. For instance, 
Tran et al. used steady state fluorescence spectroscopy and partial least squares regression 
analysis to accurately predict the enantiomeric excess of independent samples of propranolol, 
naproxen, and warfarin.
86
 We note that differences in fluorescence lifetime of enantiomers in 
presence of a CIL have also been used as a measure of chiral discrimination.
87
 In this 
dissertation, steady state has been used for enantiomeric discrimination of various fluorescent 
and non-fluorescent chiral analytes using amino acid based CILs. 
1.2.1.3.3. Chiral Discrimination Using CILs in Near Infrared (NIR) Spectroscopy  
The use of NIR for chiral discrimination is particularly appealing due to fast analysis time 
and inexpensive instrumentation. In addition, almost all organic molecules and most inorganic 
molecules are known to have NIR absorption of C-H, O-H, N-H or C=O overtone and 
combination transition. This makes the non-destructive NIR spectroscopy a potentially universal 
technique for chiral discrimination of guest-host complexes. An example of the practical utility 
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of near infrared (NIR) spectroscopy for chiral discrimination has been demonstrated by Tran and 
coworkers using S-[(3-chloro-2-hydroxypropyl) trimethylammonium] [bis((tri-
fluoromethyl)sulfonyl)amide] CIL.
88
 As noted with NMR and fluorescence spectroscopy, the 
diastereomeric complexes formed by the interaction between the chiral selector and chiral 
analyte leads to different NIR spectra. Using regressional analysis, the enantiomeric composition 
of chiral analytes such as atenolol could be accurately and sensitively determined.
88
 
1.3. Chirality and Its Significance  
Chiral analyses continues to be a subject of great interest because it has been established that 
enantiomers of a chiral racemic drug may display different properties.
89
 Enantiomers are 
stereoisomers that are non-superimposable mirror images of each other.
90
 It is well established 
that enantiomers of a chiral molecule have the same physical and chemical properties in an 
achiral medium, but different properties in a chiral environment.
90
 Based on this differential 
interaction with chiral drugs, one enantiomer of a chiral drug may have the desired medicinal 
properties while the other enantiomer may be harmful.
89, 91
 Examples of the effects of different 
enantiomeric forms of drugs is provided (Table 1.1).
91
 The effect of different enantiomeric forms 
of drugs was witnessed in the 1960s for thalidomide which as administered as a racemate at the 
time. The incident is sometimes referred to as “thalidomide tragedy” due to the teratogenic 
effects (birth defects) caused by the S-enantiomer despite the potency of the R-enantiomer in the 
treatment of morning sickness in expectant women.
92-94
  
Due to different effects caused by different enantiomers, the FDA has issued a mandate 
that requires verification of the enantiomeric form of the drug.
95
 This has led to a new trend 
called “racemic switch” implying that even drugs previously approved as racemates are being 
sold as single enantiomers.
95
 As a result of the policy requirements, the pharmaceutical industry 
are striving to produce and market enantiomerically pure drugs.
96, 97
 Thus there is a need to 
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develop various chiral selectors and suitable analytical methods to distinguish enantiomers. An 
effort towards meeting this goal is the subject of part of this dissertation.  
Table 1.1.  Effects of enantiomeric and racemic forms of various drugs (adapted from reference 
91). 
 
Drug  Uses  Effect of enatiomeric or racemic form 
of drug  
Albuterol   Bronchodilator - L- form therapeutic 
 
- Racemate cause irregular heartbeat 
Citalopram  Antidepressant  -R- enantiomer ineffective 
Fluoxetine  Prevents migraines - S- enantiomer potent 
 
- Racemate has no effect 
Ritalin Treat attention deficit 
disorder in children 
-D- enantiomer is 13 times more potent 
than L- enantiomer  
Thalidomide  Antiemetic to treat morning 
 sickness in expectant women 
 -S- enantiomer is teratogenic (causes   
Birth defects) 
 







, and crown ethers
101
 have been widely used because of their chiral recognition 
abilities. However, the use of many current chiral selectors is often limited due to low 
solubility, difficult organic syntheses, instability at high temperature, as well as high cost. In 
addition, many currently available chiral selectors require the use of another solvent and 
sometimes more than one solvent system if the analyte and the chiral selector are not soluble 
in the same solvent. Therefore, there is a need for the development of new chiral selectors that 
can be used simultaneously as solvent and chiral selector. CILs meet this requirement and 
have been explored as alternative chiral selectors as noted earlier. 
 In this dissertation, CILs derived from amino acid esters have been synthesized and used 
for enantiomeric recognition of various chiral analytes. The choice of amino acid esters is 
based on their inherent chirality thus no chiral induction is required in preparation of the 
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corresponding CILs. In addition, anion exchange from the commercially available amino acid 
ester chlorides affords CILs in a single step. Furthermore, amino acid esters have been shown 
to afford low melting point CILs compared to the amino acid counterparts due to reduced 
hydrogen bonding.
102
 The intrinsic fluorescence of some amino acids enables the preparation 
of fluorescent CILs for the enantiomeric recognition of analytes with reduced fluorescence 
emission. This dissertation explores the use of both fluorescent and non-fluorescent CILs for 
enantiomeric recognition of fluorescent and non-fluorescent analytes.  
Spectroscopic techniques including NMR and fluorescence spectroscopy were used for 
enantiomeric recognition studies of various chiral analytes in presence of CILs. UV-vis was 
used to determine the absorbance and absorption wavelength maxima of the samples before 
fluorescence analysis. CD was used to investigate the chiral integrity of the synthesized CILs. 
These spectroscopic techniques are discussed briefly in the following section.  
1.4. Spectroscopic Techniques 
1.4.1. UV-Vis Absorption Spectroscopy 
UV-vis absorption is molecular characterization technique used for analysis of molecules that 
absorb ultraviolet and visible light. A schematic of a UV-vis absorption spectrophotometer is 
shown (Figure 1.4).
103
 The light source produces radiant energy that passes through a 
monochromator which selects the desired wavelengths. The beam splitter results in two beams of 
light through the sample and the reference cells respectively. The two light outputs 
(transmittances) are amplified and their ratios (or log of ratios) are electronically amplified 
giving a measure of absorbance. The absorbance is proportional to concentration according to 
Beer‟s law equation; A = εbc, where A is the absorbance, ε is molar absorptivity, b is sample 





Figure 1.4. Schematic representation of a UV-vis spectrophotometer. 
 
1.4.2. Circular Dichroism Spectroscopy 
Circular dichroism (CD) is an optical technique used to determine the optical 
configuration of chiral molecules. Enantiomers of a chiral molecule have opposite CD bands 
indicating rotation of circularly polarized light in opposite directions. CD technique was used to 
confirm retention of chiral configuration of the synthesized CILs. A schematic of a CD 




Figure 1.5. Schematic representation of a CD spectropolarimeter. (M, monochromator; P, 




The light from the source passes through a monochromator which selects the desired 
wavelengths. The circularly polarized light is absorbed on the basis of chirality of the molecules 
in the sample. The transmitted light is elliptically polarized hence the term ellipticity used to 
describe CD measurements. A second photomultiplier detector is necessary when difference CD 
is required. This is achieved by reflecting the light from the sample through the reference using a 
mirror into the second detector. 
1.4.3. Fluorescence Spectroscopy 
In this study, fluorescence spectroscopy was used for enantiomeric recognition studies of 
various chiral analytes. In addition, it was used to investigate the spectral properties of 
fluorescent GUMBOS and nanoGUMBOS. Fluorescence is the radiative transition between 
states of the same multiplicity. The processes involved in molecular fluorescence is illustrated by 
the Jablonski diagram (Figure 1.6).
105, 106
  
Light absorption (A) from the ground state to the higher electronic states takes place on 
the order of femtoseconds (10
-15
s). According to the Franck Condon principle, we can assume 
that no nuclear displacement occurs in such a short time and therefore all transitions are vertical. 
The absorbed light undergoes internal conversion (IC) to the lowest vibrational level of S1, a fast 
relaxation process that occurs on the order of picoseconds (10
-12
s). This is followed by 
fluorescence within about 10
-8
s as the photon returns to the ground state. Since the energy of 
emission is lower than that of absorption, fluorescence occurs at a longer wavelength (Stokes 
shift). The emission spectrum is a mirror image of absorption spectrum (Franck Condon 
principle). In the excited S1 state, molecules can undergo spin conversion to the first triplet state 
(T1). This process is called intersystem crossing (ISC) and occurs at a longer wavelength than 
fluorescence. Heavy atoms such as bromine and iodine tend to enhance phosphorescence by 
facilitating ISC. 
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Light from the source (mostly xenon lamp) passes through the monochromators to select 
excitation and emission wavelengths. The gratings in the monochromators decrease stray light. 
The emitted light from the sample monchromator is at 90° configuration to the excitation light 
(Figure 1.7). This is to minimize the intense excitation light from reaching the detector which 
would otherwise lead to poor detection of the relatively less intense fluorescence signal. The 
light through the sample is detected usually with a photomultiplier tube and quantified with 





















A = photon absorption 
F= fluorescence emission 
IC= internal conversion 
ISC= intersystem crossing 
P= phosphorescence 






Figure 1.7. Schematic representation of a fluorometer. 
1.5. Ionic Liquids and Nanotechnology 
ILs have been traditionally sought for use as solvents in various reactions. Interestingly, 
although ILs are defined as organic salts with melting point at or below 100°C, there has been 
little attention paid to ILs that exist in the solid state above room temperature. This is evidenced 
by disappointment expressed by various researchers in the field of ILs whenever they obtain 
solid products in their quest for RTILs. The pursuit for RTILs has actually led to investigations 
such as using compressed CO2 to depress the melting point of frozen ILs.
107
 Such an example 
emphasizes that the focus on ILs research is mainly on the RTILs as further exemplified by the 
following excerpt from the article by Scurto and coworkers, “Often useful functional groups 
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yield solid salts.  A methodology or process to increase the range of ionic compounds for use as 
solvents would be highly useful.”
107
  Another example in which obtaining solid ILs was regarded 
as unfortunate since RTILs was desired is in the synthesis of amino acid CILs as solvents for 
asymmetric synthesis by Bao and coworkers.
108
 Further examples in which the desired solvent 
properties of RTILs sometimes proved elusive precluding the application of TSILS include their 
uses in metal extraction
23
 and enantioselective synthesis.
73
 
To our knowledge, the Warner group set the first precedence that would possibly open an 
opportunity for frozen ILs by preparing novel nanomaterials.
109
 Such IL nanomaterials are 
expected to have properties of ILs. In addition, they can be tailored to produce nanomaterials 
with properties that meet specific tasks by careful choice of the cation and the anion. Even more 
interestingly, the high melting point of the salts is no longer a limitation, and therefore more 
applications for these nanomaterials may be realized. This idea also comes in the wake of 
tremendous interest in ILs over the last two decades as reflected by the steeper than exponential 
growth in the number of publications and patents as shown earlier (Figure 1.1).
18
 Interestingly, 
the number of publications and patents in the field of nanotechnology also increased steadily in a 
fashion somewhat similar to that of ILs over the last decade.
110, 111
 The steady increase in 
nanotechnology papers and patents is illustrated in Figure 1.8.
111
 It is with the consideration of 
unique and interesting properties of ILs and nanomaterials that our research efforts focused on 
preparation of nanomaterials from ILs. Consequently these materials have been termed Group of 
Uniform Materials Based on Organic salts (GUMBOS). In this dissertation, we explore the 
synthesis of near infrared (NIR) fluorescent GUMBOS and nanoGUMBOS for potential 











Figure 1.8. Annual growth of nanoparticle research (A) publications, and (B) patents from 1990-
2009. Note that data for 2009 is for part of the year, only upto July. (Adapted from reference 
111). 
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1.5.1. NIR Fluorescent GUMBOS and NanoGUMBOS for Biomedical Imaging 
 
1.5.2. Significance of NIR Spectral Region as a Diagnostic Window 
 
Dyes that emit light in the NIR region have potential applications in areas such as 









, probes for photodynamic therapy
116





NIR fluorescent nanoparticles are of considerable interest for in vivo 
imaging because of the low absorption coefficient of human skin tissue in the long NIR 
wavelength region (700-1100 nm) (Figure 1.9).
120-122
 This results in a high signal to noise ratio 
due to minimum autofluorescence from tissues. Since light scattering is inversely proportional to 
the fourth power of wavelength, there is less scattering in the long NIR wavelength region.
123
 








Figure 1.9. (a) Absorption coefficient of human skin tissue as a function of wavelength (Adapted 
from reference 120), and (b) Absorption extinction coefficient (on a log scale) as a function of 






1.5.3. NIR Fluorophores for in vivo Imaging 
Ideally, in vivo imaging requires NIR dyes with strong absorbance and fluorescence 
emission in the NIR spectral range, photostable, as well as devoid of phototoxic effects.
121, 124
 In 
addition, the NIR dyes should be safe and easily cleared from the body.
121, 124
 In reality, 
obtaining such NIR dye that meets all the requirements is a challenge. Several materials have 
been explored for their emission properties in the NIR region including quantum dots
125-127
, 











, and organic dyes.
135, 136
 However, there are safety 
concerns on the use of most of these materials. For instance, despite their high 
photoluminescence efficiency, the microbial toxicity of quantum dots is well documented.
137
 
Single walled carbon nanotubes are also useful for photothermal cancer therapy
130
; however, the 
nanotubes have proven to significantly retard embryo development in zebrafish raising safety 
concerns.
138
 Due to these safety concerns, indocyanine green (ICG) is currently the only NIR 
organic dye approved by the FDA for use in humans.
136, 139, 140
 The low toxicity of ICG (LD50 of 





 and monitoring blood flow.
143
 Table 1.2 provides a summary of the merits 
and limitations of some of the aforementioned NIR emitting materials.  
Clearly, there is a limited number of NIR emitting materials for biomedical applications. 





 and  protein binding.
146
 This suggests that 
there is need to explore new NIR fluorescent materials for biomedical imaging applications.This 
dissertation describes our research efforts towards preparation of new class of NIR fluorescent 
materials we refer to as GUMBOS (Group of Uniform Materials Based on Organic Salts) for 
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biomedical imaging. The GUMBOS were subsequently used to make nanoGUMBOS for 
biomedical imaging applications. 
The use of contrast agents for early detection of diseased tissues such as tumors is 
advantageous for early disease treatment.
147
 For instance, NIR contrast agents have been used for 
non-invasive imaging of the lymphatic system to evaluate drainage in cancerous patients.
148
 This 
is possible because tumors generally tend to be more permeable to the contrast agents due to 
enhanced permeability and retention effect (EPR) attributed to poor lymphatic drainage by 
cancerous cells.
149, 150
 The EPR phenomenon is illustrated in Figure 1.10.
150
 The use of 
nanoparticles as contrast agents is particularly attractive because their small size (defined as 1-
100 nm)
150
 permits them to escape renal filtration and accumulate in the leaky tumor cells.
150, 151
 
In addition, various studies have shown that fluorescent nanoparticles may exhibit amplified 
signal as well as prolonged in vivo stability.
152-155
 
Most contrast agents used for bioimaging are encapsulated in some form of delivery 
agent such as silica or polymeric nanoparticles.
153, 156
 Such nanoparticle systems have suffered 
from dye leakage or encapsulation inefficiencies.
153, 156
 In an effort to alleviate these problems, 
we explore the fabrication of NIR fluorescent nanoGUMBOS without doping or encapsulating 
the dye. In addition, the GUMBOS are expected to enjoy the properties of frozen ILs such as 
negligible vapor pressure and the capability of tuning the properties by judicial choice of cation 
and anion. The GUMBOS were prepared via anion exchange of the fluorescent NIR halide with 
various anions. The nanoGUMBOS were synthesized using a simple, additive free 
reprecipitation method and their bioimaging potential was explored by Vero cell labeling and 
imaging using fluorescent microscopy. The synthesis, characterization and biomedical imaging 
potential of these new NIR nanoGUMBOS are discussed in the following sections. 
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Organic dyes -Safety: IndoCyanine Green 
(ICG), an organic dye is the only 
NIR dye approved by FDA for 
use in humans 
 
-Have desired photophysical 











Quantum dots  
-Photostable 
 
-Have high luminescence 
efficiency 
  
-Low molar absorptivity and 
quantum yield in NIR spectral 
region 
 
-Absorption and emission size 
dependent 
 






Fluorescent proteins  Useful for live cell fluorescence 
imaging  
-Limited colors available 
 





Figure 1.10. Nanoparticles exit blood vessels in the tumor owing to the enhanced permeability 
and retention (EPR) effect. (Adapted from reference 150). 
 
1.5.4. Synthesis of NanoGUMBOS 
In general, there are several methods used to prepare nanoparticles such as aerosol preparation, 
sol-gel process, microemulsions templates and reprecipitation methods. In this dissertation, the 
nanoGUMBOS were fabricated using simple, additive free reprecipitation method by dispersing 
the nanoGUMBOS in water at room temperature. 
1.5.4.1. Reprecipitation Method for the Synthesis of NIR NanoGUMBOS 
The reprecipitation method being simple and additive free has been employed for the 
preparation of various organic nanoparticles.
157-160
 In the reprecipitation method used in this 
study, the target compound is first dissolved in an organic solvent (such as alcohols, acetonitrile 
or acetone) to obtain a millimolar (mM) concentration range. This is followed by rapid injection 
of a few microlitres of the solution into a vigorously stirred (or sonicated) poor solvent (water is 





target compound takes place in the poor solvent affording nanoparticles dispersed in the 
dispersion medium. An example of the reprecipitation process for the synthesis of NIR 
nanoGUMBOS described in this dissertation work is depicted in scheme 1.3.  
We note that hydrocarbon solvents (such as hexane, heptane, and iso-octane) may be 
used as poor sovents for nanoparticle fabrication of water soluble compounds. The only 
requirement is that the target compound should be soluble in corresponding hydrocarbon 
miscible solvents such as acetone. It is also interesting that the nanoparticle dispersion has the 
same color as the dissolved stock solution. There are factors that affect the shape, size and 
spectral properties of reprecipitated nanoparticles such as the concentration of the injected 






Scheme 1.3. Scheme of reprecipitation process of nanoGUMBOS fabrication showing (A) 1 mM 
stock solution of NIR GUMBOS solution in ethanol, (B) injection of 100 µL of the NIR 
GUMBOS solution into 5 mL of deionized water while stirring or sonicating the mixture at room 
temperature, and (C) reprecipitation of NIR GUMBOS to afford NIR nanoGUMBOS dispersed 
in water.  
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1.6. Characterization of NanoGUMBOS 
 
The size and size distribution of the resultant nanoparticle suspension was determined using 
dynamic light scattering (DLS). The shape and size of the nanoGUMBOS was further confirmed 
using electron microscopy such as transmission electron microscopy (TEM). In addition, the 
aforementioned UV-vis and fluorescence spectroscopy was used to analyze the spectral 
properties of the nanoGUMBOS. The use of nanoGUMBOS for biomedical imaging was 
evaluated by cellular labeling studies using Vero cells and an epifluorescent microscope was 
used for cell imaging. These instrumental techniques are discussed briefly in the following 
section. 
1.6.1. Dynamic Light Scattering (DLS) 
DLS is among the techniques used for particle size determination based on the scattering of laser 
light. Other light scattering methods include static light scattering (SLS), photon correlation 
spectroscopy (PCS) and quasi-elastic light scattering (QELS). DLS was used to determine the 
size of particles investigated in this dissertation. In DLS, light scattered from nanoparticle 
surface in all directions is recorded as a function of time.
161
 This is in contrast to SLS in which 
the scattered light is colleted as a function of direction. The Brownian motion of particles is 
correlated to the fluctuations in intensity of scattered light.
161
 The diffusion coefficient is 
obtained from this relationship enabling the determination of the particle size from the Stokes-
Einstein equation:   
r = kBT/6πηD 




; T is the temperature in 








1.6.2. Transmission Electron Microscopy (TEM)  
TEM is an electron probe technique in which a beam of electrons is transmitted through 
the specimen resulting in formation of an image due to the interaction of electrons with the 
sample.
161
 The specimen needs to be a few nanometers (~ 100 nm) in thickness (i.e. ultrathin) in 
order to be transparent to the electron beam. In addition, the electron beam is operated in a 
vacuum (achieved using pumps) to avoid the deflection of the lighter electrons by the relatively 
heavier gas molecules.
161
 A schematic representation of a TEM microscope is shown in Figure 
1.11. 
 
Figure 1.11. Schematic representation of TEM microscope. 
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The electron gun produces a stream of electrons accelerated at high voltage (100-400kV). 
The electrons are accelerated by an anode through an aperture via the condenser lens which 
focuses the electrons onto the sample. The sample is usually dropcasted onto a copper coated 
carbon grid (100 µm thick, 3 mm diameter). The electrons transmitted through the sample passes 
through another aperture onto an objective lens and are projected for viewing onto the phosphor 
fluorescent screen by the projector lens. The CCD camera captures the “shadow” of the image 
based on the density of the sample components.
161
 
The advantages of using TEM imaging include high resolution (in the range of 0.05 nm) 
and the capability to image any type of sample including conductors, semiconductors and 
insulators.
161
 However, TEM has some limitations such as extensive sample preparation which is 
time consuming, limited number of samples that can be imaged, small field of view, change in 
structure and morphology of the sample due to high electron energy which also leads to damage 
of biological samples. In addition, the requirement of vacuum conditions increases the cost of 
TEM operation and maintenance. 
1.6.3. Fluorescence Microscopy 
Fluorescence imaging is widely used in both medicine and biological sciences. To our 
knowledge, the use of fluorescence imaging in the field of medicine was first reported in 1924. It 
was observed that the endogenous porphyrins exhibited autofluorescence in tumors when 
irradiated with ultraviolet light.
162
 Since then, fluorescence has evolved into a highly developed 
imaging system with the use of fluorescein
163
 and NIR fluorophores
118
 to image brain tumors. 
NIR fluorophores have since gained more popularity due to the aforementioned advantages such 
as better light penetration and minimum autofluorescence in the NIR wavelength range. In this 
dissertation, cellular uptake of the NIR nanoGUMBOS by Vero cells was monitored using an 
epifluorescent microscope.  
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In principle, fluorescence microscopy involves irradiation of the sample with the 
appropriate band of wavelengths, and detection of the emitted light. In an epifluorescent 
microscope which was used for this study, the excitation and observed fluorescence is from 
above (epi-) the sample. A diagram illustrating an epifluorescent microscope is shown below 
(Figure 1.12). 
 
Figure 1.12. Schematic diagram of an epifluorescent microscope. 
As depicted in Figure 1.12 above, the excitation light from the lamp source passes 
through an excitation filter where desired wavelengths are selected. The selected wavelengths 
reach the dichroic mirror tilted at 45-degree angle which reflect the light at a right angle through 
the objective onto the sample. In this study, the sample represents the Vero cells labeled with 
NIR fluorescent nanoGUMBOS. The fluorescence emission from the irradiated sample is 
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collected by the objective forming a fluorescent image. Since the emitted light is of longer 
wavelengths than excitation light (due to the aforementioned Stokes shift), it can pass the 
dichroic mirror through the emission filter onto the detector (CCD camera was used to capture 
the images in this study). We note that a Zeiss Axiovert epifluorescent microscope used in this 
study incorporates the light source, the excitation filter, dichromatic mirror, and emission filter 
into an optical block referred to as a cube. 
1.7. Fluorescent NIR Aggregates 
The NIR nanoGUMBOS described in this dissertation displayed spectral properties that 
were strikingly different from that of the corresponding GUMBOS dilute solution. Such spectral 
differences have been associated with and may be due to formation of molecular dye aggregates. 
This observation prompted our investigation of the type of aggregation that may be exhibited by 
the NIR fluorescent nanoGUMBOS. Current extensive research in molecular dye aggregation is 





and light emitting diodes.
166
  
There are two types of molecular dye aggregates namely, J and H-aggregates. The J-





 In this pioneering work, a high concentration of a pseudoisocyanine 
(PIC) dye depicted in Scheme 1.4 exhibited a narrow red shifted absorption band compared to 
the monomer.
168, 169
 In addition, the fluorescence emission had narrow band and small Stokes 
shift. Initially Scheibe postulated that this was due to reversible polymerization of 
chromophores.
169
 This observation is now ascribed to strong coupling between transition dipole 





Scheme 1.4. Pseudoisocyanine chloride (PIC). 
Since their inception, considerable attention has been paid to molecular dye aggregates 
due to the aforementioned potential applications. In addition, the possibility of both H and J 
aggregates exhibiting superradiance, a phenomena resulting from cooperative emission has 
sparked tremendous interest in studies of molecular self assemblies.
172, 173
 Conceptually, the 
molecules are arranged in a “brickwork” manner in J-aggregates whereas in H-aggregates, the 






Figure 1.13. Representation of molecular arrangements in aggregates showing (A) “brickwork” 
arrangement in J aggregates and (B) “card-pack” arrangement in H-aggregates).  
 
An energy level diagram has been proposed by several groups to explain the dye aggregation 
phenomenon.
175-177
 In general, the type of aggregate formed is determined by the type of 
B 
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transitions from the excitonic interactions between electronically coupled chromophores. Large 
hypsochromic shift in absorption typical for dye H-aggregates is attributed to transition dipole 
interactions between two or more chromophores (H-aggregates) arranged parallel to each other 
with a small dislocation (Fig. 1.14 ).
177
 The excited state is split into two components m+ and 
m , due to the interaction of two transition dipoles M1 and M2. There is a parallel arrangement 
of the molecules in H-aggregates and the allowed m+ state has a higher energy than the m  state 
and the excited monomer (Fig. 1.14), leading to hypsochromic shift in absorbance compared to 
the monomer. Note that the m+ state undergoes fast internal conversion process to the non-
emitting m  state accounting for quenched emission in H-aggregates and a large Stokes shift 
(Figure 1.14).
177
 In contrast, the allowed m+ state in J-aggregates has a lower energy relative to 
the monomer leading to bathochromic shift in absorbance. In addition, there is no internal 
conversion to an intermediate non-emitting state and hence J-aggregates are highly fluorescent 
with a small Stokes shift (Figure 1.14). 
Several factors affect the type of aggregates formed including dye structure, dye 
concentration, solvent polarity, pH, ionic strength, and temperature.
178
 It is worth noting that the 
properties of dye aggregates may also be influenced by interaction with biomolecules.
174
 For 
instance, such an interaction may enhance the low fluorescence quantum yield of H-aggregates 
while quenching the more fluorescent J-aggregates. The fluorescence enhancement phenomenon 
have been utilized by Gabor and coworkers for non-covalent labeling of the biomolecules.
174
 It is 
envisaged that an understanding and characterization of the tunable aggregates formed by the 
NIR nanoGUMBOS described in this dissertation will be useful in exploiting the full potential of 




Figure 1.14.  Proposed energy diagram for the formation of H- and J- dye aggregates and the 
resulting absorption and fluorescence properties. The blue and red blocks represent dye 
molecules, solid arrows mark the absorption, broken arrows the fluorescence and wavy arrows 
the internal conversion, crossed lines are forbidden transitions. m+ and m  are the splitted 
excitonic states whereas only m+ is allowed for light transitions. (Adapted from reference 177). 
 
1.7.1. Characterization of NIR NanoGUMBOS Aggregates: Fluorescence Anisotropy 
 
In addition to UV-vis spectroscopy and steady state fluorescence spectroscopy described 
earlier, fluorescence anisotropy was used in this study to determine the predominant aggregation 
type in the NIR nanoGUMBOS as a function of varying the anion. We note that fluorescence 
anisotropy has been used extensively to study aggregation behavior of various fluorophores.
179-
182
 Most of these studies reveal that molecular stacking in H aggregates results in slower 
rotational diffusion and higher anisotropies. However, the enhanced intermolecular interactions 
often lead to quenched fluorescence. In contrast, the less rigid head-to-tail arrangement in J 
aggregates leads to higher rotational diffusion and lower anisotropies. Due to less intermolecular 
interactions, J aggregates are usually highly fluorescent. In this dissertation, fluorescence 
anisotropy for dilute GUMBOS solution and nanoGUMBOS was used to determine the 




The principle of fluorescence anisotropy is photoselective excitation of fluorophores by 
polarized light.
106
 Figure 1.15 illustrates the measurement of fluorescence anisotropy. The 
sample is excited with vertically polarized light and the emission through the polarizer is 
measured.  There is preferential absorption of photons with electric vectors aligned parallel to the 
transition moment of the fluorophore. This process called photoselection results in polarized 
emission. The intensity observed is either parallel (Ivv) or perpendicular (Ivh) to the direction of 
polarized excitation.
106
 Anisotropy is calculated from the values of Ivv and Ivh: r = (Ivv-
GIvh)/(Ivv+2GIvh), where G is the grating factor that has been included to correct the wavelength 
response for polarization response of the emission optic and the detector. Ivv and Ivh are the 
fluorescence intensity measured parallel and perpendicular to the vertically polarized excitation, 
respectively. Anisotropy is dimensionless and does not depend on total intensity of the sample.
106
 
In contrast to polarization, anisotropy is normalized to total intensity (IT): IT = Ivv-2Ivh.  
Depolarization processes may be intrinsic due to inherent properties of the fluorophore or 
extrinsic due to factors such as rotational diffusion and resonance energy transfer (RET).
106
 The 
main source of extrinsic depolarization is rotational diffusion within the lifetime of the excited 
state. In aqueous non-viscous solutions, the anisotropy is near zero since the molecule can rotate 
extensively during the excited state lifetime. In contrast, a fluorophore bound to a 
macromolecule or in a rigid microenvironment has higher anisotropy due to restricted rotation. 
Resonance energy transfer (RET) also results in decreased anisotropy. RET occurs in 
concentrated solutions where the average distance between fluorophores is small enough to 
induce the transfer of energy between a donor and acceptor molecule. The resulting radiationless 
transfer of energy reduces the anisotropy considerably. Minimizing the effects of RET simply 
requires the dilution of the system being investigated. In general, fluorescence anisotropy has 
been used to provide information such as size and shape of proteins, protein interactions and 
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rigidity of the molecular environment.
106
 In this study, fluorescence anisotropy was used to 




Figure 1.15. Schematic diagram depicting the measurement of fluorescence anisotropy. 
 
1.8. Scope of the Dissertation 
This dissertation has two main parts namely; the use of CILs for spectroscopic enantiomeric 
recognition and the synthesis of novel fluorescent NIR nanoGUMBOS for biomedical imaging. 
Chapter 1 outlines useful background information related to the dissertation work mainly 
covering ILs, CILs and fluorescent NIR GUMBOS and nanoGUMBOS. In Chapter 2, the 
synthesis of novel CILs and investigation of their enantiomeric recognition properties is 
described. In this study enantiomeric recognition was carried out using 
19
F NMR and 
fluorescence spectroscopy exclusively on chiral fluorescent analytes. Chapter 3 extends the 
enantiomeric recognition studies to include fluorescent and non-fluorescent analytes using a 
fluorescent amino acid CIL as a potential universal selector. Chapter 4 entails the preparation of 
a new class of fluorescent NIR GUMBOS and nanoGUMBOS for biomedical imaging 
applications. Chapter 5 focuses on the characterization of tunable aggregates formed by 
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nanoGUMBOS so as to exploit their full potential based on their tunable spectral properties. 
Chapter 6 summarizes the overall conclusions drawn from the entire dissertation and provides 
suggestions on future research prospects deemed feasible based on the findings described in the 
dissertation. 
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SYNTHESIS AND CHARACTERIZATION OF NOVEL CHIRAL IONIC LIQUIDS AND 






Ionic liquids (ILs) are a class of organic salts that melt at or below 100°C. These 
compounds typically contain an organic cation with delocalized charge and a bulky inorganic 
anion. ILs that that exist in the liquid state at room temperature are termed room temperature 
ionic liquids (RTILs). Interest in room temperature ionic liquids continues to grow because of 
their potential as greener solvent alternatives to conventional environmentally damaging organic 
solvents.
1
 In addition, ILs have unique properties such as lack of measurable vapor pressure, 
high thermal stability, and recyclability.
1-5
 Such environmentally-friendly properties make ILs 
relatively benign solvents for cleaner processes to minimize toxic chemical wastes which have 
become a priority for chemical industries.
6
 Room temperature ILs have been used in various 









 and in enzymatic 
reactions.
12
 In addition, analytical applications of ILs such as their use as buffers in capillary 
electrophoresis
13
, as stationary phases in gas chromatography
14, 15
 as well as high performance 
liquid chromatography
16
, and enhancement of sensitivity in thermal lens measurement have also 
been investigated.
17





Reproduced in part with permission from Chirality, 2008, 20, 151-158; Bwambok, David K.; 
Marwani, Hadi M.; Fernand, Vivian E.; Fakayode, Sayo O.; Lowry, Mark; Negulescu, Ioan; 
Strongin, Robert, M.; Warner, Isiah M.; Synthesis and characterization of novel chiral ionic 
liquids and investigation of their enantiomeric recognition properties, copyrighted to Wiley-Liss 
Inc. in 2007.  
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by Baker and coworkers.
18 
In addition, Baker and his coworkers have developed an optical 
sensor based on an ionic liquid.
19
   
Analyses of chiral molecules are very important since different enantiomers of a chiral 
racemic drug may display different properties.
20
 For example, one enantiomer of a chiral drug 
may have the desired medicinal properties, while the other enantiomer may be harmful. Various 
chiral selectors, such as cyclodextrins, molecular micelles, antibody, and crown ethers have been 
widely used because of their chiral recognition abilities.
21-24
 However, the use of many current 
chiral selectors is often limited due to low solubility, difficult organic syntheses, instability at 
high temperature, as well as high cost. In addition, many currently available chiral selectors 
require the use of another solvent and sometimes more than one solvent system if the analyte and 
the chiral selector are not soluble in the same solvent. Therefore, there is a need for the 
development of new chiral selectors that can be used simultaneously as solvent and chiral 
selector. Thus, the use of chiral ILs have gained popularity since they can be used as chiral 
solvents for asymmetric induction in synthesis.
25
 Chiral ILs can also serve as chiral stationary 
phases in chromatography as demonstrated by Armstrong and coworkers in gas 
chromatography.
26
 Tran and coworkers have also recently used chiral ILs for determining the 
enantiomeric composition of pharmaceutical products.
27, 28  
To our knowledge, 1-butyl-3-methyl imidazolium lactate reported in 1999 by Seddon and 
his coworkers is among the first chiral ionic liquids synthesized.
29
 This chiral ionic liquid, with a 
chiral anion, was prepared via anion metathesis using 1-butyl-3-methyl imidazolium chloride and 
sodium (S)-2-hydroxypropionate. This ionic liquid also afforded good endo/exo selectivity in a 
Diels Alder reaction. Recently, ionic liquids with chiral carboxylates have been synthesized by 
Allen and coworkers.
30
 This synthesis was achieved in water by reacting tetrabutylammonium 




synthesized chiral ILs from chiral starting materials affording many different 
chiral ILs in good yields.
31
 A novel imidazolium based chiral ionic liquid with planar chirality 
was synthesized by Saigo, et al. in 2002.
32 
However, this ionic liquid could only be obtained as a 
racemic mixture and required further separation of the enantiomers before investigating its 







cations have been synthesized. However, chiral precursors for ILs are often used in a multi-step 
synthesis. A detailed review of chiral ionic liquid synthesis has been reported.
37
 Kou, et al. have 
also successfully prepared chiral ionic liquids from amino acids and their corresponding methyl 
and ethyl esters.
38
 These chiral ionic liquids from amino acid esters had low melting points 
compared to those derived from amino acids. Other interesting amino acid derived chiral ionic 
liquids have also been synthesized recently.
39-42
 Armstrong and Ding
 
have successfully 
synthesized chiral ILs via a simple anion exchange between a commercially available halide salt 
with N-lithiotrifluoromethanesulfonimide.
42
 This approach provides an attractive one step 
synthesis with a chiral precursor, while allowing the product to be easily purified by washing 
with water.
 
The same approach was employed by Tran et al. to prepare chiral ILs.
27 
The variety 
and applications of these ILs suggest that other chiral ILs need to be explored in order to obtain 
ILs for different applications.  
  Natural materials are often used as precursors for preparing chiral ILs in multiple step 
synthesis. As an example, the use of amino acids for preparation of imidazolium cations is clear 
evidence of such use.
33
 Chiral induction in some reactions may be required to afford chiral ILs, 
mostly in one enantiomeric form. In addition, the few commercially available chiral ILs are often 
very expensive. The high cost, combined with the difficulty in chiral ionic liquid synthesis, has 
limited their extensive study and applications.  
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The primary objective of this study was to synthesize and characterize both enantiomeric 
forms of new chiral ILs from commercially available amino acid ester chlorides. The presence of 
a chiral center in the precursor further simplifies the synthesis, alleviating the need for 
asymmetric induction. In addition, esterification reduces hydrogen bonding of amino acids 
affording low melting point ILs.
38
 By varying the anions, the synthesis of ILs can be tailored, 
resulting in ionic liquids of different properties that may be used for various applications. In 
addition, this study reports an investigation of the enantiomeric recognition ability of a variety of 
chiral amino acid ester based ILs. The synthesis of chiral ILs was accomplished via a simple 
anion metathesis reaction and characterization was performed using nuclear magnetic resonance 
(NMR), thermal gravimetric analysis (TGA), differential scanning calorimetry (DSC), circular 
dichroism (CD), and elemental microanalysis. The relatively simple synthetic procedure and the 
presence of chiral centers in the precursors is a tremendous advantage for our approach. Finally, 
the chiral recognition ability of L- and D- alanine tert-butyl ester bis (trifluoromethane) 
sulfonimide ionic liquid was evaluated using 
19
F NMR with a racemic Mosher‟s sodium salt 
substrate and fluorescence spectroscopy with some chiral fluorescent analytes.  
2.2. Methods 
2.2.1. Chemicals and Materials 
L- and D-alanine tert butyl ester hydrochloride [L- and D-AlaC4Cl)], bis(trifluoromethane) 
sulfonimide lithium salt (LiNTf2), silver tetrafluoroborate (AgBF4) , silver lactate (AgLac), silver 
nitrate (AgNO3), 2-methoxy-2-(trifluoromethyl) phenylacetic acid (Mosher‟s acid), and methanol 
(ACS certified) were purchased from Sigma Aldrich Chemicals (Milwaukee, WI). In addition, 
enantiomerically pure R- and S- enantiomers of warfarin, naproxen and 2,2,2-
trifluoroanthrylethanol (TFAE) were purchased from Sigma Aldrich Chemicals (Milwaukee, 
WI). All chemicals were used as received. 
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2.2.2. General Instrumental Methods 
The NMR spectra were recorded in d6-DMSO on a Bruker-250 MHz instrument with tetramethyl 
silane (TMS) as an internal standard. Melting point (Tm) was determined by differential scanning 
calorimeter using a thermal analysis instrument TA SDT2960 at a scanning rate of 5 °C min
-1
. 
Thermal decomposition temperature (Tdec) of ILs was determined with a thermal analysis 
instrument 2950 TGA HR V6.1A (module TGA 1000 °C). The heating rate for TGA was 5 °C 
min
-1
 under nitrogen from 25 °C to 300 °C. A Jasco-710 spectropolarimeter was used to obtain 
the CD spectra of our ILs. Steady-state fluorescence measurements were recorded at room 
temperature by use of a Spex Fluorolog-3 spectrofluorimeter (model FL3-22TAU3; Jobin Yvon, 
Edison, NJ, USA) equipped with a 450-W xenon lamp and R928P photomultiplier tube (PMT) 
emission detector. Fluorescence emission spectra were collected in a 4 mm quartz fluorescence 
cuvet with slit widths set for entrance exit bandwidths of 4 nm on both excitation and emission 
monochromators for warfarin, 2 nm for TFAE, and 1.5 nm for naproxen, respectively. 
Fluorescence for warfarin, TFAE, and naproxen were respectively monitored at excitation 
wavelengths of 306, 365, and 280 nm. In addition, all fluorescence spectra were blank subtracted 
before data analysis. 
2.2.3. 
19
F NMR Experiment 
Racemic Mosher‟s sodium salt was prepared from Mosher‟s acid by reacting with an equivalent 
of sodium hydroxide in water and the salt was dried under vacuum before 
19
F NMR 
measurement. The racemic Mosher‟s sodium salt (8.38 mg, 0.03 mmol) and 129.07mg (0.3 
mmol) of L- or D- AlaC4NTf2 were dissolved in 0.75 ml of d6 DMSO. The mixture was shaken 
vigorously for 10 minutes on an orbital shaker before recording 
19




2.2.4. Synthesis of L- and D-Alanine tert Butyl Ester bis (trifluoromethane) Sulfonimide, 
AlaC4NTf2 
 
An amount of 0.5 g (2.75 mmol) of L- or D-alanine tert butyl ester chloride was dissolved in 
water. An equimolar amount (0.79 g, 2.75 mmol) of bis (trifluoromethane) sulfonimide lithium 
salt was dissolved separately in water. The two solutions were mixed and stirred for 2 hrs at 
room temperature. The mixture resulted in two layers, of which the lower layer was separated 
and dried under vacuum overnight. This resulted in 0.94g (79 % yield) of colorless ionic liquid. 
Scheme 2.1 depicts the anion exchange reaction between L-alanine tert butyl ester chloride and 


































Scheme 2.1. Synthesis of L-AlaC4NTf2 
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The decomposition temperature (Tdec) of this ionic liquid was found to be 263 °C by use of 
TGA measurements. 
1
H NMR (250 MHz, d6 DMSO) δ (ppm) 8.19 (s, 3H), 3.97 (q, 1H), 1.45 (s, 
9H), 1.36 (d, J = 7.0 Hz, 3H).
 13
C NMR δ (ppm) 170.12, 83.66, 49.19, 28.32, 16.69. Anal. Calcd. 
for C9H16N2O6S2F6 : C, 25.35; H, 3.78; N, 6.57. Found: C, 25.07; H, 3.98; N, 6.52. 
2.2.5. Synthesis of [L- and D-Alanine tert Butyl Ester] Nitrate, Tetrafluoroborate, and 
Lactate  
 
The synthesis of both enantiomeric forms of alanine tert butyl ester CIL containing nitrate, 
tetrafluoroborate and lactate anions is summarized in scheme 2.2. The synthesis of L- alanine tert 
butyl nitrate is described as a representative procedure to outline the experimental details of the 
anion exchange reaction with these anions. The procedure is similar for tetrafluoroborate and 
lactate anion exchange except we replace the nitrate anion with the corresponding lactate or 
























Y = NO3, BF4, Lac  
 
Scheme 2.2. Synthesis of AlaC4NO3, AlaC4BF4, and AlaC4Lac 
2.2.5.1. Representative Procedure: Synthesis of L-Alanine tert Butyl Ester Nitrate  
A tenth of a gram, i.e. 0.1 g (0.55 mmol) of L- AlaBuCl was dissolved in methanol. An 
equimolar amount of silver nitrate (0.0935 g, 0.55 mmol) was suspended separately in methanol. 
The two solutions were mixed and stirred, and the precipitate was then filtered. The product was 
evaporated in vacuo and purified by crystallizing in methanol/ether to obtain 0.08 g (77 % yield) 
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of the product L-AlaC4NO3 as white crystals (Tm, 104 °C).
 
This ionic liquid was thermally stable 
up to 130 °C. 
1
H NMR (250 MHz, d6 DMSO) δ (ppm) 8.36 (s, 3H), 3.92 (q, 1H), 1.44 (s, 9H), 
1.35 (d, J= 7.0 Hz, 3H). 
13
C NMR δ (ppm) 170.05, 83.51, 49.18, 28.36. Anal Calcd. for 
C7H16N2O5: C, 40.38; H, 7.75; N, 13.45. Found: C, 44.97; H, 8.53; N, 9.03. 
2.2.5.2. L-alanine tert Butyl Ester Tetrafluoroborate 
Yield: 80%.Tm, 93 °C ; Tdec, 125 °C.
 1
H NMR (250 MHz, d6 DMSO) δ (ppm) 8.18 (s, 3H), 3.94 
(q,1H) 1.45 (s,9H), 1.36 (d, J = 7Hz, 3H). 
13
C NMR δ (ppm) 170.13, 83.68, 49.19, 28.38, 16.74. 
Anal. Calcd. for C7H16NO2BF4: C, 36.08; H, 6.92; N, 6.01. Found: C, 35.71; H, 7.31; N, 6.13. 
2.2.5.3. L-Alanine tert Butyl Ester Lactate 
Yield: 86%. Tm, 114 °C; Tdec, 132 °C. 
1
H NMR (250 MHz, d6 DMSO) δ (ppm) 5.53 (s, 3H), 3.79 
(q, 1H), 3.62 (q, 1H), 1.40 (s, 9H), 1.25 (d, J=7 Hz, 3H) 1.15 (d, J=6.75, 3H). 
13
C NMR δ (ppm) 
209.50, 178.31, 173.10, 110.00, 81.97, 67.28, 49.91, 28.46, 21.87, 18.98. Anal Calcd. for 
C10H21NO5: C, 51.05; H, 8.99; N, 5.95. Found: C, 50.85; H, 8.96; N, 5.96. 
2.3. Results and Discussion 
2.3.1. Synthesis and Characterization of a New Amino Acid Ester Chiral Ionic Liquid (L- 
or D-AlaC4NTf2) 
 
The synthesis of both enantiomeric forms of alanine tert-butyl ester bis (trifluoromethane) 
sulfonimide was accomplished via anion metathesis reaction of the corresponding amino acid 
ester chloride and bis (trifluoromethyl) sulfonylimide lithium salt (Scheme 2.1). The reaction 
proceeded well in water with good yield (79%) of L - or D-alanine tert-butyl ester bis 
(trifluoromethyl) sulfonylimide (L- or D-AlaC4NTf2). The 
1
H NMR (Fig. 2.1) and 
13
C NMR 

















Figure 2.1. Proton (
1
H) NMR spectrum of L-AlaC4NTf2 in d6 DMSO with tetramethyl                         
silane (TMS) as an internal standard at room temperature. 
 
 
The NMR spectra obtained for other ILs were very similar to that of AlaC4NTf2. The 
similarity in NMR spectra was expected since only the anions were varied. The alanine tert-butyl 
ester bis (trifluoromethyl) sulfonylimide ionic liquid was found to be a desirable liquid at room 
temperature and stable up to 263 ºC, as indicated by thermal gravimetric analysis (TGA) 
measurement (Fig. 2.3A). 
The ionic liquid L-AlaC4NTf2 was also heated at 225 ºC for 2 hours to verify and confirm 
whether decomposition occurs at a lower temperature. From Fig. 2.3B, it seems that at this 
isothermal plateau (225 °C), there is a constant rate loss of 0.42%/min for the span of 120 min. 
The constancy of the weight loss rate might be an indication that a physical phenomenon (e.g. 
evaporation), rather than a chemical decomposition process, is occurring. The rather low 
decomposition temperature for the BF4 salt (125 ºC), is still uncertain and may not be solely due 
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to the cation instability upon moderate heating. This is because as much as the cation might not 
be very stable at moderate heating, the same cation had relatively higher stability (263 ºC) with 























Figure 2.2. Carbon-13 NMR spectrum of L-AlaC4NTf2 in d6 DMSO with tetramethyl silane 
(TMS) as an internal standard at room temperature. 
  
 The high thermal stability of alanine tert-butyl ester bis (trifluoromethyl) sulfonylimide 
makes it a preferred chiral selector and chiral solvent for reactions at high temperature or as a 
coating in gas chromatography. It is indeed extremely important that the chiral center in the 
precursor be retained in the final ionic liquid product. According to Jodry and Mikami, some 
imidazolium CILs will sometimes undergo racemization after synthesis.
34 
The possibility of 
racemization in the synthesized ILs was investigated by use of circular dichroism (CD) 
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measurements of the ionic liquid products and their precursors. Examples of the CD bands 


























Figure 2.3. Thermal gravimetric analysis of L-AlaC4NTf2 with a heating rate of 5 °C min
-1
 under 


























































































As expected, the CD bands of the precursors were in the same direction as those of the ionic 
liquid products, confirming retention of configuration. In addition, the opposite CD bands 
confirmed that the L- and D- configurations of the ILs had been retained (Fig. 2.4). 
 
 
Figure 2.4. Circular dichroism spectra of  L- and D- (A) AlaBuCl, (B) AlaBuBF4, (C) 
AlaBuNO3, and (D) AlaBuNTf2 at room temperature.  
 
2.3.2. Chiral Recognition Study of ILs Using 
19
F NMR 
As previously noted, L- and D- alanine tert-butyl ester bis (trifluoromethane) sulfonimide are 
liquids at room temperature. It was therefore interesting to investigate their ability to act both as 
solvent and chiral selector. The chiral recognition ability of L- and D-alanine tert-butyl ester bis 
(trifluoromethane) sulfonimide was investigated by use of 19F NMR and racemic Mosher‟s 
sodium salt. In this experiment, various solvents such as methylene chloride, deuterium oxide, 
dimethyl sulfoxide (DMSO) as well as chloroform were examined. However, d6-DMSO 
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demonstrated good solubility as compared to other solvents investigated. The results of the 19F 
NMR study for enantiomeric recognition ability of L- and D- alanine tert-butyl ester bis 





















F NMR spectra of (A) racemic sodium Mosher‟s salt; and a mixture of the 




to a shift in the 
19
F NMR signal of the racemic Mosher‟s sodium salt. In addition, the split in the 
19
F NMR signal of the racemic substrate by both enantiomeric forms of the ionic liquid 
demonstrates their enantiomeric recognition (Fig. 2.5). This confirms that this ionic liquid can be 
a suitable chiral selector for various applications such as determination of enantiomeric 
composition of chiral molecules of pharmaceutical, biomedical, and environmental interest.  
2.3.3. Chiral Recognition of ILs Using Fluorescence Spectroscopy 
Steady-state fluorescence spectroscopy was further used to evaluate the chiral recognition 
ability and enantio-selectivity of the chiral ILs on 2,2,2-trifluoroanthrylethanol (TFAE), 
warfarin, and naproxen chiral analytes. The choice of these chiral analytes in this study was due 
to their fluorescence properties; furthermore, they are of environmental and pharmaceutical 
interest. For instance, warfarin is an anticoagulant drug used for the treatment of 
thromboembolic diseases and is also generally used as a pesticide, while naproxen is used as an 
anti-infammatory drug. 
The emission spectra of the 10 µM R- and S-enantiomers of TFAE, warfarin, and 
naproxen analytes in the presence of L-AlaC4NTf2 chiral ILs are respectively shown in Fig. 2.6 
(A1, B1 and C1). The intensity of emission of the R-enantiomers obtained in the presence of 
ionic liquid solvent and chiral selector is noted to be higher than that of the S-enantiomers for all 
three analytes investigated. A difference in emission intensity of R- and S-enantiomers in the 
presence of chiral selectors is due to different diastereomeric interactions between the 
enantiomers and the IL chiral selectors. Such spectral differences have been widely reported and 
associated with enantioselectivity of chiral selectors as a result of diastereomeric complexes.
43-45
 
Finally, a mean-centered plot of emission spectra, obtained by subtracting each emission 
spectrum from the mean spectrum on a wavelength to wavelength basis, was used to gain better 
insight into the enantiomeric selectivity and chiral recognition ability of the chiral ILs. The mean 
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centered plot of the emission spectra depicted in Fig. 2.6 (A1, B1, and C1) are shown in Fig. 2.6 
(A2, B2 and C2), respectively. The spectra were obtained by subtracting the spectrum of R- and 
S-enantiomer in the presence of chiral selectors from the R- and S-mean spectra. It is of great 
importance to note that R- and S- enantiomers have opposite mean spectra, further demonstrating 
the chiral recognition ability and enantio-selectivity of the ionic liquid chiral selector.   
2.3.4. Synthesis and Characterization of Novel Amino Acid Ester CILs (L-or D-AlaC4NO3, 
AlaC4BF4, AlaC4Lac) 
 
A similar anion metathesis reaction used for the synthesis of AlaC4NTf2 was employed for the 
synthesis of AlaC4NO3, AlaC4BF4, and AlaC4Lac. However, the reaction was performed in 
methanol at a shorter time of five minutes (Scheme 2.2). The silver chloride precipitate was 
filtered off in each case affording good yields of the respective chiral ILs after removing 
methanol in vacuo. Alanine tert- butyl ester nitrate (AlaC4NO3) crystallized to form a white solid 
at room temperature. AlaC4BF4 was obtained as a colorless greasy solid, whereas AlaC4Lac 
forms clear needle-like crystals at room temperature. The fact that solid ILs were obtained upon 
changing the anion demonstrates the tunability of the ILs synthesized in this study. By varying 
the anion or cation, different ILs with different properties are obtained for various applications. 
These results illustrate that bis (trifluoromethane) sulfonimide is probably a poorly coordinating 
anion with an alanine tert butyl ester cation. The poor crystal packing between the anion and 
cation results in ionic liquid. Del Po‟ polo describes this as frustrated packing between a bulky 
inorganic anion and cation leading to lower melting point ILs.
46 
Their findings are in agreement 
with our results that bis (trifluoromethane) sulfonimide being the largest of the anions yielded an 
ionic liquid product that was liquid at room temperature. The other smaller anions such as nitrate 
afforded ILs that were solid at room temperature. 
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Figure 2.6. Fluorescence emission and mean centered spectral plots of 10 µM R- and                        
S- (A) TFAE, (B) warfarin, and (C) naproxen enantiomers in the presence of L-AlaC4NTf2 chiral 
ionic liquid. The emission spectra of TFAE, warfarin, and naproxen were monitored at excitation 
wavelength of 365, 306, and 280 nm, respectively, at room temperature. 
 
2.4. Conclusions 
In summary, we have successfully synthesized a series of new chiral ILs in both 
enantiomeric forms using a simple metathesis reaction between the chiral chloride ester salt and 
the corresponding anion sources. Alanine tert-butyl ester bis (trifluoromethane) sulfonylimide is 
desirably liquid at room temperature and is thermally stable up to 263 ºC. It can therefore be 
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used in high temperature reactions or as a chiral selector in gas chromatography. Furthermore, 
the ILs presented here have the same chiral configuration as the chloride salt precursors 
indicating that enantiomeric salts were obtained upon anion metathesis. Both enantiomeric forms 
of alanine tert-butyl ester bis (trifluoromethane) sulfonylimide ionic liquid demonstrated 
enantiomeric recognition of racemic Mosher‟s sodium salt. This is an advantage since the ionic 
liquid can serve both as solvent and chiral selector, alleviating the need for use of 
environmentally damaging solvents to dissolve the analyte. As an example, this compound could 
probably be used to provide chiral selectivity in the determination of enantiomeric composition 
of pharmaceutical products and in chiral separations. While the solid ILs could not be used for 
this purpose, we believe that their synthesis and characterization is a step towards exploring their 
potential applications. 
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A FLUORESCENT AMINO ACID-BASED CHIRAL IONIC LIQUID FOR 
POTENTIAL UNIVERSAL ENANTIOMERIC DISCRIMINATION 
 
3.1. Introduction 
Enantiomers of chiral drugs often differ in their pharmacological activities and 
pharmacokinetic profiles as a result of their interactions with optically active molecules in the 
human body and other biological systems.  For example, one enantiomer may have the desired 
medicinal activity, while the other may be inactive or show a qualitatively different effect or 
quantitatively different potency, and/or lead to extreme toxicity.
1
 Over the past decade, the 
marketing of single enantiomers of chiral drugs has become more common, with single 
enantiomers now being the leading component of drugs approved today.
2, 3
 This is partly due to 
the Food and Drug Administration‟s 1992 policy statement regarding the development and 
regulation of new stereoisomeric drugs
4
, combined with the pharmaceutical industry‟s use of 
“chiral switching” strategies to manage drug life-cycles and remarket established racemates as 
single enantiomers.
2, 5
 Thus, there is a need for the development of methods to quantitatively 
determine enantiomeric purity. 












, and crown ethers
26, 27
. However, the use of many of these chiral selectors is 
often hindered with problems such as low solubility of either the analyte or selector in the 
solvent of choice, difficult multi-step syntheses, and instability at high temperatures. Thus, 
complex solvent mixtures may sometimes be required to dissolve the analyte and the chiral 
selector when they are not both soluble in the same solvent. We believe that multiple solvation 
interactions, as provided by ionic liquids (ILs), may provide a solution to this problem.
28
 For 
example, a given IL may dissolve a variety of polar and non-polar analytes, while a chiral ionic 
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liquid (CIL) may simultaneously induce the required chiral selectivity.
29
 Moreover, unlike many 
other chiral selectors, CILs do not require inclusion of the analyte into a selector‟s cavity to 
provide discrimination, thus adding to their universality. In addition, ILs are often quite simple to 
prepare. Many one-step synthesis of ILs, including CILs, from commercially available reagents 
have been reported. ILs are also known to be stable at high temperatures as evidenced through 
their many uses as separation reagents in gas chromatography.
30, 31
 Therefore, the many useful 
properties of CILs may minimize some of the problems often encountered with other forms of 
chiral selectors.  
Chiral ionic liquids belong to the more general class of compounds referred to as ionic 
liquids or sometimes as room temperature ionic liquids. ILs are classified as organic salts whose 







, synthesis or catalysis
37
, and beyond 
has been widely reviewed.
38
 Chiral ionic liquids are ILs in which either the cation, or the anion, 
or both may be chiral. One example of a series of CILs possessing either a chiral cation, chiral 
anion, or both, has been recently reported.
39
 The cations of these molecules consisted of an 
imidazolium group, while the anions were based upon a borate ion with spiral structure and 
chiral substituents. A growing interest in CILs is demonstrated by an increasing number of new 
classes of CILs reported in the literature, including the amino acid-based CILs used in this work. 
The synthesis, characterization, and applications of various CILs have been thoroughly described 
in several recent reviews.
40-44
 
Chiral ionic liquids have recently gained popularity in part based on their many potential 
applications, e.g. their utility as chiral stationary phases in gas chromatography
30, 31
, and as 
additives for enantiomeric separations in micellar electrokinetic electrochromatography
45
 or high 
performance liquid chromatography.
31
 The development of ILs based on amino acids which are 
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chiral, biocompatible, biodegradable, and also display reduced toxicity have also increased the 
popularity of CILs. Ohno and co-workers reported amino acid-based ILs composed of 
imidazolium cations and amino acid anions and speculated as to their potential utility.
46
 
Subsequently, several other reports of amino acid-based ILs have appeared. Amino acid-based 
ILs were recently reviewed
47, 48




Despite the numerous syntheses of CILs which have been reported, surprisingly only a 
limited number of studies have used spectrophotometric measurements to investigate their 
enantiomeric discrimination properties.
29
 One example can be cited which uses near infrared 
absorption to determine the enantiomeric compositions of pharmaceutical products using a novel 
CIL as both the solvent and selector.
49
 By taking advantage of the high sensitivity of 
fluorescence detection, the same group extended the technique to  enantiomeric determination of 
intrinsically fluorescent chiral analytes, including propranolol, naproxen, and warfarin.
50
 In 
related work, our group has recently reported the enantiomeric discrimination of amino acid-
based CILs towards intrinsically fluorescent analytes.
51
 Yet, there continues to be a need for a 
simple, universal approach to measure enantiomeric compositions at low concentrations. High 
sensitivity fluorescence detection provides a possible approach.  However, since many analytes 
of interest display minimal intrinsic fluorescence emission, it would be advantageous to include a 
fluorescent reporter as part of the IL for such an approach.  
While it has been reported that many ILs, or their impurities, display fluorescence when 
excited at 280-430nm, the origin of this fluorescence has not yet been explained.
33
 Additionally, 
a series of highly photoluminescent benzobis(imidazolim) salts was recently described by 
Bielawski and co-workers and an application of this new class of versatile fluorescent materials 




 However, universal fluorescence detection in the measurement of enantiomeric 
compositions using a CIL as the solvent, selector, and reporter, would require a fluorescent CIL. 
Such a fluorescent CIL should be capable of acting simultaneously as solvent, selector, and 
fluorescent reporter; thus, high sensitivity detection would also be possible for non-fluorescent 
analytes. The intrinsic fluorescence of aromatic amino acids suggests possibilities for such a 
fluorescent CIL. 
Herein, we report the synthesis and characterization of a fluorescent amino acid-based 
chiral ionic liquid, L-PheC2NTf2, and the investigation of its enantiomeric discrimination 
capabilities. To the best of our knowledge, this is the first report on the use of a fluorescent CIL 
as a solvent and chiral selector for enantiomeric discrimination of non-fluorescent as well as 
fluorescent analytes.  
3.2. Materials and Methods 
3.2.1. Chemicals and Materials 
L-phenylalanine ethyl ester hydrochloride [L-PheC2Cl], bis (trifluoromethane) sulfonimide 
lithium salt (LiNTf2), 2-methoxy-2-(trifluoromethyl) phenylacetic acid (Mosher‟s acid), 
methanol (ACS certified), Ludox® AS-40 colloidal silica (40 Wt% suspension in water), 
tetramethyl silane (TMS), deuterated solvents, pure enantiomeric forms of fluorescent analytes: 
2,2,2-trifluoroanthrylethanol (TFAE), 1,1′-binaphthyl-2,2′-diamine (BNA), and propranolol, and 
non-fluorescent analytes: camphanic acid, serine, glucose, and mannose were purchased from 
Sigma Aldrich Chemicals (Milwaukee, WI). All chemicals were used as received without further 
purification. Ultrapure water (18.2 MΩ·cm) was used for all purposes and obtained from an Elga 




3.2.2. General Instrumental Methods 
A Jasco-710 spectropolarimeter was used for measuring Circular Dichroism (CD) spectra of 
room temperature methanolic solutions (1 mM L-PheC2NTf2) in 1 cm quartz cells. The thermal 
decomposition temperature (Tdec) was determined using a thermal analysis instrument, 2950 
TGA HR V6.1A (module TGA 1000 °C), at a heating rate under nitrogen of 5 °C min
-1
 from 25 
°C to 300 °C. The NMR spectra were recorded using a Bruker-250 MHz instrument and using 




C NMR, d6-DMSO was used as 
the solvent, whereas CD2Cl2 with 30% d6-DMSO was used for 
19
F NMR measurements.  
Absorption measurements were acquired at room temperature using a Shimadzu, model 
UV-3101PC UV-vis-NIR spectrophotometer with samples either in 4 mm square quartz cells, or 
between two quartz plates in the case of the neat L-PheC2NTf2 film. Steady-state and frequency-
domain lifetime fluorescence measurements were recorded using a Spex Fluorolog-3 
spectrofluorimeter (model FL3-22TAU3; HORIBA Jobin Yvon, Edison, NJ). Excitation was 
provided by a 450 W xenon arc lamp. Dual monochromators were used to select the excitation 
and emission wavelengths with bandpasses of 3nm each. The integration time was set to 0.1 sec 
per point, and 950 V were applied to a Hamamatsu R928 PMT. All fluorescence spectra were 
ratio corrected through division by the signal from a reference detector which monitored the 
lamp output.  
Excitation-Emission Matrix spectra (EEMs) were collected in 4 mm square quartz cells 
with excitations from 250-400nm and emission from 250-500nm using 2.5nm and 5nm step sizes 
for emission and excitation, respectively. An adjacent averaging routine was performed on all 
EEMs in order to improve signal quality. The fluorescence quantum yield was measured in a 1 
cm path-length quartz cell with right-angle collection geometry following the comparative 
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method reported by Williams et al.
54
 A quantum yield of 0.27 for anthracene in ethanol was used 
as the reference.  
Fluorescence decay times were measured using a variable frequency phase-modulation 
technique. Full-sized 1 cm quartz cells were used with 330nm excitation. The emission was 
collected through a 370nm long pass filter. Thirty-one logarithmically spaced frequencies were 
collected over a frequency range of 10–136.9 MHz using five averages and a 10 sec integration 
time at each frequency. Frequency-domain measurements were collected versus Ludox, a scatter 
reference solution, which showed a lifetime of 0 nsec. Phase and modulation decay profiles were 
analyzed using the Globals software package developed at the Laboratory for Fluorescence 
Dynamics (University of Illinois at Urbana-Champaign). Constant phase and modulation errors 
of 0.5° and 0.005 were used in analyses for consistency and ease of day-to-day data 
interpretation. 
3.2.3. Synthesis of L-Phenylalanine Ethyl Ester bis (Trifluoromethane) Sulfonimide (L-
PheC2NTf2) 
 
The procedure was similar to that used in the preparation of alanine-based CILs previously 
reported.
51
 Specifically, 10 g (43.53 mmol) of L-phenylalanine ethyl ester chloride (L-PheC2Cl) 
was dissolved in water and mixed with an aqueous solution of 12.49 g (43.53 mmol) of bis 
(trifluoromethane) sulfonimide lithium salt (LiNTf2). The mixture was stirred for more than 2 hrs 
at room temperature. The ionic liquid was quite hydrophobic and did not dissolve in water. The 
ionic liquid was higher in density than water and thus formed the lower layer of a bilayer system 
when mixed and stirred with water. The lower layer containing L-PheC2NTf2 was separated and 
washed five times with water. It was observed that as the number of washes increased, a slight 
yellow color in the ionic liquid completely disappeared. Subsequently, the ionic liquid was dried 
using a lyophilizer, yielding 17.49 g (83% yield) of clear, colorless, slightly viscous, but free 
flowing ionic liquid. The decomposition temperature (Tdec) was determined using TGA and 
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found to be 270 ºC. Characterization by 
1
H NMR and 
13
C NMR showed the peaks consistent 
with the chemical structure of the ionic liquid. 
1
H NMR (250 MHz, d6 DMSO) δ (ppm) 8.3 (s, 
3H), 7.34-7.21 (m, 5H), 4.28 (t, J = 7.5 Hz, 1H), 4.12 (q, 2H), 3.02-3.16 (ddd, J = 6.4, 7.5, 13.2 
Hz, 2H), 1.10 (t, J = 7.2 Hz, 3H).
 13
C NMR δ (ppm) 169.91, 135.35, 130.28, 129.44, 128.16, 
62.57, 59.50, 54.02, 14.53. These results were confirmed using elemental analysis. Calculated 
for C13H16N2O6S2F6 : C, 32.91; H, 3.40; N, 5.90. Found: C, 32.00; H, 3.79; N, 5.31. 
3.2.4. Circular Dichroism (CD) Measurements of CIL Liquid and Precursor 
A concentration of 1.00 mM (10
-3
 M) stock solution was prepared by dissolving the precursor, L-
PheC2Cl (2.29 mg) and the CIL, L-PheC2NTf2 (4.74 mg) in 10 mL of methanol. The CD 
spectra were then recorded using a Jasco 710 spectropolarimeter. Methanol was used as the 
blank and was substracted from the CD data of the CIL and the precursor. The retention of chiral 
configuration after prolonged heating was investigated by comparison of CD spectra of 1 mM 
methanolic solutions prepared from neat L-PheC2NTf2 at room temperature to that of a 
corresponding CIL solution in which the neat L-PheC2NTf2 had been heated in the oven for more 
than 18 hrs at 115 ºC. 
3.2.5. Sample Preparation for Fluorescence Spectroscopy 
A concentration of 1.00 mM (10
-3
 M) stock solution of R or S (or L or D)- enantiomer was 
prepared by dissolving appropriate weight in 25 mL of ethanol (or water in case of glucose 
analyte) using a calibrated 25 mL volumetric flask. Equal concentrations of 10 µM (10
-5
 M) of R 
or S (or D or L)- enantiomer were prepared by pipetting 5 µL of each stock solution (10
-3
 M)  
into a vial, allow the solvent (water for glucose and ethanol for the rest of the analytes) to 
evaporate under a gentle stream of ultrapure nitrogen and finally adding 500 µL (0.5 mL) of neat 
L-PheC2NTf2. This was followed by sonication for 20 mins, vortexing and finally fluorescence 
measurements were made using a 4 mm cuvet after equilibrating the sample for 10 mins.  
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3.3. Results and Discussion 
3.3.1. Confirmation of Chirality and Stability Upon Extended Heating 
One of the goals of the current study is to demonstrate the chiral discrimination of L-
PheC2NTf2 when used simultaneously as the solvent and selector. Therefore, the chiral integrity 
of the CIL product was important as some CILs have previously been reported to undergo 
racemization during synthesis, although its precursor was enantiomerically pure.
55
 Circular 
dichroism measurements of L-PheC2NTf2 product ionic liquid (1 mM in methanol) and its chiral 
starting material, PheC2Cl (1 mM in methanol), were conducted to confirm the retention of the 
chiral configuration upon the ion-exchange. The CD spectral band of the L-PheC2Cl precursor is 
positive (data not shown), the same shape and direction as that of the L-PheC2NTf2 product, thus 
suggesting the retention of chiral configuration. It is also important to confirm the retention of 











Figure 3.1.  Circular dichroism spectra of 10
-3
 M L-PheC2NTf2 in methanol at room temperature 
(broken line), and corresponding 10
-3
 M L-PheC2NTf2 in methanol prepared from neat L-


























through comparison of CD spectra of 1 mM methanolic solutions prepared from neat L-
PheC2NTf2 at room temperature to that of a corresponding CIL solution in which the neat L-
PheC2NTf2 had been heated in the oven for more than 18 hrs at 115 ºC. As shown in Figure 3.1, 
this CIL does not racemize after prolonged heating. 
 Thermal analysis by TGA revealed that L-PheC2NTf2 is stable to thermal 
decomposition up to 270 ºC (Figure 3.2 A). It has been observed that upon prolonged heating, 
some ILs decompose at temperatures lower than their measured decomposition temperatures.
56, 57
 
This observation prompted us to heat L-PheC2NTf2 for 30 minutes at a constant temperature of 
225 ºC. A minimal loss of mass was observed (Figure 3.2 B). Results obtained from these studies 
suggest that this CIL is relatively stable when heated for a long period of time and may be 
potentially suitable as a solvent medium for high temperature reactions and as a chiral stationary 
phase in gas chromatography. 
Weight (%)
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Figure 3.2. Thermal gravimetric analysis of neat L-PheC2NTf2 under nitrogen, with a heating 
rate of 5 °C min
-1
 from (A) 25 to 350 °C (B) 25 to 225°C, then isothermally at 225 °C for 30 
minutes.  
 
3.3.2. Screening of Enantiomeric Discrimination Using 
19
F NMR 
 The enantiomeric discrimination properties of L-PheC2NTf2 were investigated using the 
diastereomeric interaction towards classical racemic Mosher‟s sodium salt. A binary solvent 
system consisting of CD2Cl2 with 30% d6 DMSO was used to dissolve the mixture of racemic 
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Mosher‟s sodium salt and L-PheC2NTf2. The 
19
F NMR spectrum of Mosher‟s salt in the absence 
of L-PheC2NTf2 displayed only a single band at 69.803 ppm (Figure 3.3 A). Addition of L-
PheC2NTf2, 142.30 mg (0.3 mmol), to the racemic Mosher‟s sodium salt, 8.38 mg (0.03 mmol), 
resulted in peak splitting, as well as a shift to 70.832 and 70.876 ppm (Figure 3.3 B). The 
difference in the chemical shifts (Δδ) was calculated as 11 Hz. This is an indication of strong 
diastereomeric interactions between the racemic Mosher‟s sodium salt and the CIL, suggesting 




Figure 3.3. Enantiomeric recognition of Mosher‟s salt by L-PheC2NTf2. 
19
F NMR spectra of (A) 
racemic sodium Mosher‟s salt; and (B) a mixture of the racemic sodium Mosher‟s salt with L-
PheC2NTf2 at room temperature. 
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3.3.3. Spectroscopic Properties of L-PheC2NTf2 
The absorption and fluorescence properties of L-PheC2NTf2 were studied as neat CIL (Table 3.1) 
and using ethanol as a solvent as needed (Figure 3.4). These data are presented in Table 3.1. Neat 
L-PheC2NTf2 was observed to be colorless. A thin film of neat L-PheC2NTf2 displayed a 
maximum absorption at 257nm and a spectral shape similar to the characteristic phenylalanine 
amino acid absorbance. However, unlike phenylalanine and L-phenylalanine ethyl ester 
hydrochloride (a CIL precursor), L-PheC2NTf2 displayed a weakly absorbing tail in its 
absorption spectrum extending to wavelengths beyond 400nm as compared to the characteristic 
absorption of phenylalanine. The absorption spectra of neat L-PheC2NTf2 in a 4 mm path-length 
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 320, ~400 
~340, ~400 
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a 
 Properties of neat ionic liquid. A thin film (~29 µm) of neat L-PheC2NTf2 between two 
quartz plates displayed a spectral shape similar to phenylalanine. Neat ionic liquid in a 4 mm 
path-length cell displayed an absorption greater than 3 at wavelengths below ~270nm, ~0.1 near 
350nm, and ~0.05 at 400nm. 
 
b  
Properties of neat ionic liquid. Front face collection geometry was used in an effort to 
minimize inner filter effects. 
  
c  
Properties of neat ionic liquid. Frequency-domain measurements were collected versus 
Ludox, a scatter reference solution, which showed a lifetime of 0 nsec. Full-sized 1 cm quartz 
cells were used with 330nm excitation. The emission was collected through a 370nm long pass 
filter. Fractional contributions of each lifetime are shown in parentheses. 
 
d  
The high absorbance of the neat L-PheC2NTf2 necessitated using dilute ethanolic solutions in 
the determination of its quantum yield. A quantum yield of 0.06 was calculated upon excitation 
at 257nm in a 1 cm path-length quartz cell with right-angle collection geometry. 
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cell (Figure 3.2) displayed an absorbance of ~0.1 near 350nm decreasing to ~0.05 at 400nm. 
Absorption was greater than 3 at wavelengths below ~270nm. It is also interesting to note that 
subtle differences appeared in the spectral region between 280-320nm as L-PheC2NTf2 was 
diluted in ethanol (Figure 3.4).  
The high absorbance of the neat L-PheC2NTf2 necessitated using dilute ethanolic 
solutions in determination of its quantum yield. A quantum yield of 0.06 was calculated for L-
PheC2NTf2 dissolved in ethanol upon excitation at 257nm. For comparison, this value is slightly 
greater than the value of 0.022 reported for phenylalanine amino acid in water.
58
 It should be 
noted that a low quantum yield does not preclude the use of this CIL for enantiomeric 
discrimination studies. Its use as a solvent (without dilution) resulted in sufficiently high 
concentration (molarity = 3.14 moles L
-1
, calculated based on its measured density) to obtain 
more than adequate absorption and fluorescence signal. 
The absorption spectrum of a thin film (~29 µm) of L-PheC2NTf2 between two quartz 
plates was qualitatively similar to that of a 1 mM solution of L-PheC2Cl (a CIL precursor) in 





 at 257nm, which is lower than that reported for phenylalanine amino acid dissolved 






 Decreased absorption was also observed for 0.01 M L-
PheC2Cl (a precursor of the CIL) in H2O as compared to 0.01 M phenylalanine in H2O (ratio of 
1.77 at the absorption maxima) which accounts for most of the observed decrease in absorption 
for the phenylalanine-based CIL as compared to phenylalanine. The seemingly low molar 
absorptivity of L-PheC2NTf2 does not pose a problem for applications outlined for this study. In 
fact, high absorption values and the resulting inner filter effects presented greater difficulties. 
Therefore, front face collection geometry was used for fluorescence measurements in an effort to 
minimize inner filter effects. These data indicate that it was not generally practical to use 
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excitation wavelengths below ~280nm where absorption of the incident excitation light was 









Figure 3.4. Absorption spectra of neat L-PheC2NTf2, various dilutions in ethanol (EtOH), and 1 
mM L-PheC2Cl ionic liquid precursor in EtOH measured in 4 mm thick cell. Figure also includes 
29 µM thick layer of neat L-PheC2NTf2. 
 
The fluorescence Excitation-Emission Matrix (EEM) of L-PheC2NTf2 revealed complex 
fluorescence behavior with multiple excitation and emission bands for the neat CIL. The full 
EEM contour plot can be found in Figure 3.5A with a subset of emission spectra collected using 
various excitation wavelengths as shown in Figure 3.5B. Although the emission intensity was 
impacted by absorption of the incident light, excitation at 260nm (near the 257nm absorption 
maximum of L-PheC2NTf2) revealed broad overlapping emissions with peak maxima near the 
characteristic 280nm emission of phenylalanine, as well as near 320nm. The latter peak has been 
previously identified as phenylalanine excimer by Leroy et al.
60
 Longworth had also observed 
similar excimer emission for L-poly-phenylalanine in THF.
61
 Increasing the excitation 
wavelength to 280nm reduced the impact of inner filter effects as the absorption decreased. A 
prominent excimer peak at 320nm resulting from 280nm excitation provided the largest emission 


















100% neat CIL 
75% CIL in EtOH
50% CIL in EtOH
25% CIL in EtOH
100% CIL thin f ilm (~29 microns)
1mM CIL precursor in EtOH
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apparent upon excitation at 280nm, which became more readily observable as the excitation 
wavelength increased to 300nm. At excitation of 320nm, the peak at near 400nm was the only 
emission peak. Excitations greater than 320nm resulted in a red shift of this long-wavelength 
emission. Concentration-based studies conducted by Leroy et al.
60
 clearly demonstrated excimer 
emission at 320nm for a phenylalanine concentration of 0.1 M in water. However, no longer 
wavelength emitting species were reported at this concentration. It is not surprising that the 
extremely high phenyalanine concentration (3.14 moles L
-1
) occurring in neat L-PheC2NTf2 
results in much more complex spectral behavior than low concentration solutions. Explaining 
these complexities is beyond the scope of this present study.  However, it should be noted that 
imidazolium ILs have also been reported to display unconventional fluorescence behavior. In 
such solutions, fluorescence emission shifted towards the red with increasing excitation 
wavelength. This observation was attributed to the presence of energetically different associated 




The complexity observed in the steady-state EEMs was also displayed in time-resolved 
measurements. Instrumental limitations and the high absorption of neat L-PheC2NTf2 
complicated the measurements and required excitation at a longer wavelength than the 257nm 
maximum absorption of L-PheC2NTf2. In an effort to minimize inner filter effects, measurements 
were performed upon 330nm excitation with emission collected through a 370nm long pass 
filter. Leroy, et al. reported the lifetime of phenylalanine amino acid (8x10
-4
 M in H2O at 20° C) 
to be 6.8±0.2 nsec and observed a slight increase in decay time at increasing concentrations.
60
 In 
this work, three lifetime components including both significantly longer (~12 nsec) and shorter 
(<1 nsec) lifetimes were required to adequately model the decay of room temperature L-
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PheC2NTf2 (Table 3.1). The more complex decay observed for the phenylalanine-based CIL is 

















Figure 3.5. Fluorescence of neat L-PheC2NTf2 (A). Excitation-Emission Matrix (EEM), (B) 
subset of emission spectra collected with various excitation wavelengths extracted from the EEM 
at various excitation wavelengths (260-360nm in 20nm intervals).  
 
It is also interesting to note that complex spectral behavior was observed in a phenylalanine-
based fluorescent chiral molecular micelle, previously reported by our group.
19, 20
 Long-
wavelength emission and a triple exponential decay similar to that obtained for L-PheC2NTf2 









































































3.3.4. Enantiomeric Discrimination Using Steady-State Fluorescence Spectroscopy 
In these studies L-PheC2NTf2 served simultaneously as solvent and chiral selector, as 
well as a fluorescent reporter in the case of non-fluorescent chiral analytes. In the case of chiral 
analytes possessing intrinsic fluorescence, comparisons of the spectral alterations induced upon 
the analyte‟s emission as compared to those induced upon the CIL‟s emission were made. 
Equal concentrations (10 µM) of either pure R- or S- (D- or L-) enantiomer of each chiral 
analyte were dissolved into neat L-PheC2NTf2. All mixtures were prepared from ethanolic stock 
solutions of analytes (except glucose which was prepared in water). Required amounts of analyte 
stock solution were delivered into a vial; the ethanol was gently evaporated with a stream of 
nitrogen, and a known volume of L-PheC2NTf2 was added to the vials. Mixtures were shaken 
vigorously to ensure complete dissolution of the analytes.  
Structures of L-PheC2NTf2, and all fluorescent and non-fluorescent chiral analytes used 
in this study are shown in Figure 3.6. A variety of fluorescent and non-fluorescent analytes were 
chosen with a wide range of chemical structures. It is interesting to note that L-PheC2NTf2 could 
dissolve all of these structurally diverse analytes and at the same time induce spectral differences 
between enantiomerically pure forms of each pair of analytes. Chiral ionic liquids show 
discrimination by solvating, and thus requires being in the presence of the analyte.
29, 49-51
 For this 
reason, solubility is an important factor in the formation of diastereomeric complexes. In 
previous work using a phenylalanine-based molecular micelle as the chiral selector, we observed 
that the addition of methanol to aqueous solutions of analyte and selector improved the 
discrimination towards non-polar analytes.
20
 The ability of ILs to solvate a wide range of both 
relatively polar and non-polar analytes may eliminate the need for this step, thus simplifying the 





Figure 3.6. Chemical structures of chiral ionic liquid and chiral analytes investigated: A. selector 
L-phenylalanine ethyl ester bis (trifluoromethane) sulfonimide (L-PheC2NTf2), B. fluorescent 
analytes (I) TFAE (II) BNA (III) Propranolol. C. non-fluorescent analytes (I) Camphanic acid 
(II) Serine (III) Glucose (IV) Mannose. 
 
The spectral properties of neat L-PheC2NTf2 are complex, with multiple emissions upon 
using different excitation wavelengths. In order to 1) measure the response of these various 
emissions to the presence of a chiral analyte and to 2) measure the response from intrinsically 
fluorescent analytes when present, it was essential to measure the EEM over a broad range of 
excitation and emission wavelengths. The use of multiple excitation wavelengths was imperative 
because many dipolar fluorescent molecules exhibit relatively strong excitation-wavelength-
dependent fluorescence behavior in ILs.
62
 The excitation-wavelength-dependent shift of the 
fluorescence maximum has been reported to be between 10-35nm.
62
 The dynamic stokes shift 
and excitation wavelength-dependent fluorescence of dipolar molecules in room temperature ILs 
has been discussed at length.
63
 
A comparison of the emission spectrum for neat fluorescent CIL with the spectrum of 
each enantiomer dissolved in L-PheC2NTf2 for a given wavelength is informative; however, 
mean-centered spectral plots have also proven to be a valuable tool in the presentation of spectral 
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differences induced by a chiral selector; thus providing insight into the enantiomeric composition 
of mixtures.
18, 19, 51
 In this work, mean-centered plots (MCPs) were obtained by averaging spectra 
measured when pure R- and S- (or D- and L) enantiomers were dissolved in L-PheC2NTf2 and 
then these average values were subtracted from the corresponding spectra of each individual 
sample on a wavelength-by-wavelength basis. MCPs are generally useful to demonstrate the 
extent of chiral recognition displayed by a chiral selector towards a particular analyte, and for 
rapid screening of unknown samples to identify whether they are racemic or rich in one 
enantiomeric form. The best chiral selectors induce the largest spectral differences and also 
display the largest magnitudes in their MCPs. MCPs of racemic mixtures will lie on the origin, 
while MCPs of mixtures rich in one enantiomer will lie between the origin and the limiting value 
defined by the MCP of the corresponding pure enantiomer. The magnitude of the MCPs is an 
indication of the enantioselectivity displayed by a chiral selector towards a particular analyte.  
In previous studies
18, 19, 51
 a single excitation wavelength was generally chosen near the 
absorption maxima of the fluorescent analyte or fluorescent chiral selector. This greatly 
simplified the presentation of data as compared to the multidimensional fluorescence excitation-
emission matrixes (EEMs) collected in this study. Emission spectra were collected for all 
excitations between 250-400nm. For simplicity, representative excitation wavelengths were 
chosen for presentation. Emission spectra of the neat fluorescent CIL and each enantiomer 
dissolved in L-PheC2NTf2 was collected at excitation wavelengths of 280nm and 360nm. These 
wavelengths were chosen because emission from L-PheC2NTf2 was efficiently generated. 
Intrinsically fluorescent propranolol was also efficiently excited at 280nm. Long-wavelength 
emission from L-PheC2NTf2 as well as emissions of intrinsically fluorescent TFAE and BNA 
were generated by excitation at 360nm. We note that other wavelengths are also of interest. 
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3.3.4.1. Enantiomeric Discrimination of Fluorescent Analytes 
The fluorescent analytes investigated include propranolol, TFAE and BNA. TFAE and 
propranolol have asymmetric carbon and hydroxyl groups, whereas BNA has axial chirality and 
amine groups. Propranolol is a beta blocker commonly used for treatment of hypertension. BNA 
and TFAE are often used as starting materials for asymmetric synthesis.  
The presence of BNA and TFAE resulted in ~25nm red shift and slight enhancement of 
the 320nm L-PheC2NTf2 emission upon 280nm excitation; however, there was minimal 
enantioselectivity apparent in the resultant emission. The emission of propranolol in S-CHTA 
NTf2 upon 280nm excitation has been reported near 340nm with a shoulder near 350nm.
50
 Its 
emission in L-PheC2NTf2 is dim, although it appears to be similar to the emission reported 
above. It overlaps with the 320nm phenylalanine excimer peak of L-PheC2NTf2 and possibly the 
shifted emission described above if it also exists in the presence of propranolol. The long-
wavelength emission of CIL upon 360nm excitation in the presence of propranolol is quenched; 
however, there does not appear to be appreciable enantioselectivity in this spectral region. The 
emission of BNA and TFAE overlaps that of the long-wavelength L-PheC2NTf2 emission; 
however, it appears that this long-wavelength CIL emission is also quenched in a similar way as 
observed in the presence of propranolol and adds little to the chiral selectivity apparent in the 
emissions of the fluorescent analytes in this spectral region.  
A subset of mean-centered plots (excitations from 260-360nm in 20nm intervals) for 
these fluorescent analytes in the presence of L-PheC2NTf2 are shown in Figure 3.7. L-PheC2NTf2 
shows selectivity towards each of these diverse analytes. Of the data shown in Figure 3.7, the 
greatest difference was displayed for TFAE excited at 360nm. For propranolol, the greatest 
differences in emission between the enantiomers was at ~290nm. These plots demonstrate the 
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wavelength-dependent selectivity. Thus, the choice of excitation wavelengths has a major impact 
on the degree of selectivity.  
3.3.4.2. Enantiomeric Discrimination of Non-fluorescent Analytes 
Since many analytes of interest have limited or virtually no intrinsic fluorescence emission, it 
would be advantageous to measure alterations in the fluorescence emission of a fluorescent CIL, 
L-PheC2NTf2, caused by diasteromeric interactions with chiral analytes. The various non-
fluorescent chiral analytes used for this study include camphanic acid, serine, glucose, and 
mannose. Camphanic acid is a chiral auxiliary in the synthesis of aza sugars and is also used in 
the resolution of chiral alcohols. Serine is a naturally occurring amino acid useful in metabolism 
such as biosynthesis of purines and pyrimidines. It also plays important catalytic functions in 
enzymes such as trpysin and chymotrypsin. Glucose and mannose are carbohydrates, useful 
sources of energy, and are useful in protein synthesis.  
The presence of the non-fluorescent analytes, clearly induced spectral alterations to L-
PheC2NTf2. For example, a similar ~25nm red shift and slight enhancement of the 320nm L-
PheC2NTf2 emission upon 280nm excitation that was described in the presence of fluorescent 
analytes (BNA and TFAE) was also observed in the presence of camphanic acid. Interestingly, 
while this emission displayed minimal enantioselectivity in the presence of BNA and TFAE, it 
showed considerable enantioselectivity in the presence of the non-fluorescent camphanic acid.  
A subset of mean-centered plots (excitations from 260-360nm in 20nm intervals) for the 
non-fluorescent analytes in the presence of L-PheC2NTf2 are shown in Figure 3.8. L-PheC2NTf2 
shows selectivity towards each of these analytes. Comparisons of Figures 3.7 and 3.8 reveal that 
although the magnitude of differences were generally greater for 10 µM of fluorescent analytes, 
the presence of 10 µM non-fluorescent analytes induced more than adequate alterations to the 































Figure 3.7. Fluorescence mean-centered plots (MCPs) for 10 μM individual fluorescent 
enantiomers in L-PheC2NTf2 presented at various excitation wavelengths (260-360nm in 20nm 
intervals). A. Propranolol, B. BNA, and C. TFAE. Solid lines represent the R- (or D-) 





















































































































































Figure 3.8. Fluorescence mean-centered plots (MCPs) for 10 μM individual non-fluorescent 
enantiomers in L-PheC2NTf2 presented at various excitation wavelengths (260-360nm in 20nm 
intervals). A. Camphanic acid, B. Serine, C. Glucose, and D. Mannose. Solid lines represent the 
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3.3.5. Potential for Chemoselective and Enantioselective Fluorescent Discrimination of 
Monosaccharides 
 
Saccharide sensing is an extremely active area of research. There are a total of 16 
possible aldohexose stereoisomers with D-glucose, D-galactose, and D-mannose being the three 
most common hexoses present in nature. The three isomers differ only in the axial/equatorial 
configuration of their hydroxyl groups. Among these, sensing of D-glucose is of particular 
interest. There has been a large focus in recent years on boronic acid-based molecular receptors 
since their “rediscovery” in the mid 1990s.
64
 While boronic acid-sugar chemistry has been 
known for well over a century, the first rationally designed fluorescent photoinduced electron 
transfer sensor for saccharides utilizing the boronic acid-tertiary amine interaction was reported 
by the Shinkai group in 1994.
65, 66
 Boronic acid-based sensors have also been recently 
reviewed.
67
 While there has been significant progress, the development of boronic acid-based 
molecular receptors has been hampered by synthetic difficulties. Another potential difficulty is 
the cleavage of boronic acids under relatively mild conditions. 
We note that there is a large difference between the emissions of L-PheC2NTf2 in the 
presence of D-glucose as compared to D-mannose. Figure 3.9 clearly demonstrates the difference 
is excitation wavelength-dependent. The difference in emission between two individual sugar 
solutions (D-glucose minus D-mannose) of L-PheC2NTf2 is depicted as a contour map (Figure 
3.9A). A subset of slices, with various excitation wavelengths extracted from the contour map, 
are also shown for clarity (Figure 3.9B). The largest difference in emission occurs near 350nm 
upon excitation at 280nm. Excitations beyond ~350nm also lead to relatively large difference in 
the long-wavelength CIL emission in the presence of these two compounds. Thus, L-PheC2NTf2 





Figure 3.9. Fluorescence intensity differences (D-glucose minus D-mannose) between 10 μM D-
glucose and D-mannose enantiomers in L-PheC2NTf2. A. Contour plot, B. Subset of difference 
spectra collected with various excitation wavelengths extracted from the contour plot at various 
excitation wavelengths (260-360nm in 20nm intervals).  
 
The importance of chiral discrimination of monosaccharides has also been recognized. 
For example, James et al. reported the chiral discrimination of D- and L-monosaccharides using 
a chiral diboronic acid which incorporated a fluorescent naphthyl moiety.
68
 Binding of each 
enantiomer of various monosaccharides altered the fluorescence intensity of the sensor to 
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differing degrees, thus allowing them to be distinguished. Other studies in this area have been 
reported, for example consider the recent study of enantioselective and chemoselective 
fluorescent chemosensors for sugar alcohols, such as D-sorbitol and D-mannitol.
69
 
Not only does the CIL, L-PheC2NTf2, described herein, display selectivity between D-
glucose and D-mannose. It also shows selectivity toward the individual enantiomeric forms of 
each. It is informative to compare the emission spectra for glucose and mannose enantiomers in 
the presence of L-PheC2NTf2 with each other, and with the corresponding emission of neat CIL. 
It is apparent that when excited at 260nm, the sugars have minimal effect on the emission of L-
PheC2NTf2. However, at excitations greater than ~275nm, both sugars induced dramatic spectral 
alterations. For example, the presence of glucose resulted in a ~25nm red shift and slight 
enhancement of the 320nm L-PheC2NTf2 emission upon excitation at 280nm, with significant 
enantioselectivity toward glucose enantiomers apparent in this emission. Mannose did not induce 
a similar shift; rather it enantioselectively quenched the 320nm L-PheC2NTf2 emission. 
Enantioselectivity toward glucose was also displayed in the long-wavelength CIL emission and 
at longer excitation wavelengths; however, the quenching of this long-wavelength emission by 
mannose showed no enantioselectivity. The presence of each enantiomer of the two 
monosaccharides altered the fluorescence emission of L-PheC2NTf2 to differing degrees and in 
differing spectral regions, thus demonstrating the potential for chemoselective and 
enantioselective fluorescent discrimination of monosaccharides.  For this reason, this 
phenomenon will be examined further in more detail. 
3.4. Conclusions  
In summary, we have synthesized and investigated the enantiomeric recognition 
properties of a fluorescent amino acid-based chiral ionic liquid, L-phenylalanine ethyl ester bis 
(trifluoromethane) sulfonimide (L-PheC2NTf2). Such a CIL is advantageous over previously 
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reported non-fluorescent CILs, whose applications were limited to the use of less sensitive 
modes of detection such as absorption, or to the use of fluorescence in discrimination of a small 
subset of intrinsically fluorescent analytes. To the best of our knowledge, this is the first report 
on the use of a fluorescent CIL as a solvent and chiral selector for enantiomeric recognition of 
non-fluorescent as well as fluorescent analytes. Preparation of L-PheC2NTf2 was simple, using 
commercially available starting materials, and the CIL was liquid at room temperature with 
thermal stability up to 270 ºC. In addition, the chiral configuration was retained upon prolonged 
exposure to high temperatures at 115 ºC, which is indicative of the high stability of L-PheC2NTf2 
to thermal racemization, suggesting its potential as a stationary phase for chiral gas 
chromatography. Chiral discrimination studies were performed using 
19
F NMR and steady-state 
fluorescence spectroscopy. The results suggest that L-PheC2NTf2 is a potential solvent, chiral 
selector, and fluorescent reporter for enantiomeric recognition of several chiral compounds with 
a wide range of structures. L-PheC2NTf2 may also prove useful in the chemoselective and 
enantioselective fluorescent discrimination of monosaccharides. 
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NEAR INFRARED FLUORESCENT NANOGUMBOS FOR BIOMEDICAL 
IMAGING 
 
4.1. Introduction  
Near infrared (NIR) fluorescent materials have been successfully applied in areas such as 















For in vivo 
imaging applications, the low absorption coefficient of human skin tissues in the 700–1100 nm 
NIR wavelength region
11
 minimizes scattering and background interference, allowing for deep 
tissue imaging.
12
 A number of NIR-emissive materials have been exploited based on their 
desirable luminescence in this spectrally quiet region, especially those that fall in the nano-
regime. These nanomaterials include quantum dots,
13











 and  
organic dyes.
18, 19
 However, many of these nanomaterials have had concerns raised regarding 
both their environmental safety and their cytotoxicity. For instance, quantum dots have been 
reported to cause microbial toxicity
20
 and pose serious environmental safety concerns which are 
difficult to either control or predict. In this regard, the development of alternative nanomaterials 
that are biocompatible, non-toxic, and tunable, while exhibiting well-defined delivery behavior, 
is highly sought.    
When employed for biological applications such as imaging, fluorophores are typically 




 carrier particle, primarily for purposes of 
biocompatibility. However, dye encapsulation using these materials often leads to additional 
challenges such as dye leakage
21
 and permeability problems.
23
 There are also concerns that the 




Again, an urgent need remains for the development of uniform, non-leaking, and additive-free 
luminescent particles for bio-imaging.   
Within our laboratories, we have recently developed an emergent class of highly 
promising nano-materials we will collectively refer to as GUMBOS (Group of Uniform 
Materials Based on Organic Salts). A range of stable GUMBOS can be formed in the nano-
regime from ionic liquids (ILs) that melt above room temperature. In general, the low melting 
points of ILs stem from the asymmetry of the component ions and the resultant poor crystal 
packing,
25
 a feature open to design. Of course, nanoGUMBOS developed from ILs enjoy many 
of the unique properties associated with this novel class of material, including negligible vapor 
pressure, variable solubility, non-flammability, high thermal stability, ionic conductivity, and 
recyclability.
26
 In the current application, however, GUMBOS formed from ionic materials that 
do not comply with the traditional working definition of an IL and melt above 100 °C are also 
useful building blocks in GUMBOS formation. The most attractive feature of nanoGUMBOS is 
the ability to gather within the same nano-object several complementary or orthogonal 
properties, leading to the prospect of developing multifunctional GUMBOS. This designer 
characteristic borrows from lessons learned in IL technology, namely, that careful selection and 
pairing of a functional cation with a dissimilarly functional anion leads to a tailored material 
displaying bimodal properties.   
In this study, we report on a new class of fluorescent nanoparticle based on the concept of 
GUMBOS. These nanoparticles display uniform, stable NIR luminescence suitable for 
fluorescence imaging applications. The unique spectral properties of these NIR fluorescent 
nanoGUMBOS and their performance in cellular imaging studies are summarized in this work. 
To the best of our knowledge, this is the first report of IL-based NIR fluorescent nanoparticles. 
Our results suggest that nanoGUMBOS might offer unique possibilities for in vivo NIR 
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fluorescence imaging without the need for dye carriers, providing potential as contrast agents in 
other medical imaging modes as well.  
4.2. Materials and Methods 
4.2.1. Materials 
1,1′,3,3,3′,3′-hexamethylindotricarbocyanine (HMT) iodide (97%), bis (2-ethylhexyl) 
sulfosuccinate (AOT) sodium salt (≥99%), potassium 4-(trifluoromethyl) phenyltrifluoroborate 
(96%) and potassium 3,5 bis (trifluoromethyl) phenyltrifluoroborate, Sodium tetrakis[3,5-
bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borate, sodium tetrafluoroborate, sodium 
tetraphenylborate and ethanol (spectroscopic grade) were purchased from Sigma Aldrich and 
used as received. Triply deionized water (18.2 MΩ cm) from an Elga model PURELAB ultra
TM
 
water filtration system was used for all preparations of IL NIR dye nanoparticles. Vero cells 
were obtained from the School of Veterinary Medicine (Louisiana State University, Baton 
Rouge, LA). Carbon coated copper grids (CF400-Cu, Electron Microscopy Sciences, Hatfield, 
PA) were used for TEM imaging. 
4.2.2. Synthesis and Characterization of NIR GUMBOS 
The NIR GUMBOS (mostly ILs) were prepared using anion exchange procedures similar to 
those reported in the literature.
25-27
 The synthesis of 1,1′,3,3,3′,3′-hexamethylindotricarbocyanine 
bis (2-ethylhexyl) sulfosuccinate ([HMT] [AOT]) is described as a representative procedure. An 
amount of 30 mg (0.056 mmol) of 1,1′,3,3,3′,3′-hexamethylindotricarbocyanine (HMT) iodide 
and 24.86 mg (0.056 mmol) of sodium bis (2-ethylhexyl) sulfosuccinate (AOT) salt were 
dissolved in a mixture of methylene chloride and water (2:1 v/v) and allowed to stir for 12hrs at 
room temperature (Scheme 4.1). The methylene chloride bottom layer was washed several times 
with water and the product was obtained from the organic lower layer and dried by removal of 
solvent in vacuo. Further freeze drying to remove traces of water afforded 43.02 mg (93% yield) 
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of [HMT] [AOT]. All GUMBOS obtained were characterized by 
1
H NMR (Bruker 250 MHz 
spectrometer) and elemental microanalysis (Atlantic Microlab, Norcross, GA, USA). In addition, 
19
F NMR was used to confirm anion exchange for fluorine containing GUMBOS. Melting points 
of the GUMBOS was determined using a MEL-TEMP
®





























HMT AOT + NaI (aq)
 
Scheme 4.1. Synthesis of [HMT] [AOT] by anion exchange reaction 
4.2.3. Synthesis of NIR NanoGUMBOS 
The nanoGUMBOS were prepared from GUMBOS using a modified simple, additive-free 
reprecipitation method similar to that used for organic nanoparticles.
24,28-31
 The solvents used for 
preparing the nanoGUMBOS were filtered using 0.2 µm nylon membrane filters. In a typical 
preparation, 100 µL of a 1 mM solution of GUMBOS precursor dissolved in ethanol was rapidly 
injected into 5 mL of triply-deionized water in an ultrasonic bath, followed by further sonication 
for 2 min. Post-preparation, the particle suspension was aged for 1 h in the dark.  
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4.2.4. Characterization of Size and Morphology of NIR NanoGUMBOS 
The average particle size and size distribution of the prepared nanoGUMBOS were obtained by 
use of transmission electron microscopy (TEM) and dynamic light scattering (DLS). TEM 
micrographs were obtained using an LVEM5 transmission electron microscope (Delong 
America, Montreal, Canada). The NIR nanoGUMBOS dispersion (1 µL) was dropcasted onto a 
carbon coated copper grid and allowed to dry in air at room temperature before TEM imaging. 
4.2.5. X-Ray Diffraction Analysis of NIR NanoGUMBOS 
X-ray diffraction measurements of dried nanoGUMBOS were obtained on a Nonius Kappa CCD 
diffractometer by long exposures with Mo Kα radiation and rotation of samples about the 
vertical axis.  
4.2.6. Absorption and Fluorescence Studies of NIR GUMBOS and NanoGUMBOS 
Absorbance measurements were performed on a Shimadzu UV- 3101PC UV-Vis-near-IR 
scanning spectrometer (Shimadzu, Columbia, MD). Fluorescence emission was collected using a 
Spex Fluorolog-3 spectrofluorimeter (model FL3-22TAU3); Jobin Yvon, Edison, NJ). A 1 cm
2
 
quartz cuvette (Starna Cells) was used to collect the fluorescence and absorbance against an 
identical cell filled with water as the blank.  
4.2.7. Cellular Uptake Studies of Nano-GUMBOS by Vero Cells 
HMT AOT nanoGUMBOS were used as model nanoGUMBOS for Vero cellular labeling in this 
study. The choice was based on its spectral properties (absorption and fluorescence) in the NIR 
diagnostic window. In addition, literature studies suggest that both the constituent ions in HMT 
AOT are expected to have non-toxic properties. Specifically, HMT cation has been used in 
biological optical imaging. A structurally related cyanine dye and HMT have also been used as a 
probe for radionuclide and fluorescence complementary studies. In addition, the AOT anion has 
been used as an emollient (“skin softener”) in the preparation of IL-active pharmaceutical  
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ingredients with cations such as lidocaine (pain reliever), ranitidine (antihistamine) and 
didecyldimethylammonium (antibacterial). Vero cells (isolated from kidney epithelial cell lining 
extracted from an African green monkey, Cercopithecus aethiops) were used as a model cell line 
for this study using HMT AOT nanoGUMBOS. The cells were maintained in Dulbecco‟s 
Modified Eagle‟s Medium (DMEM) before studies. The Vero cells were then loaded into an 
eight well glass plate (2.5 × 10
5
 cells/well) and incubated with HMT AOT nanoparticles (8 
µg/mL) for 24 hrs. The cells are then washed twice with phosphate buffered saline (PBS) and 
immediately visualized using a Zeiss epifluorescence microscope equipped with a Zeiss digital 
camera for image acquisition. Negative controls were also prepared by loading the Vero cells 
into the wells which did not contain dye. 
4.3. Results and Discussion 
4.3.1. Synthesis, Characterization and Optical Properties of NIR GUMBOS and 
NanoGUMBOS 
 
The GUMBOS presented in this dissertation were produced from a cationic NIR core unit 
following a modification of anion exchange procedures reported elsewhere.
27-29
 We selected for 
this study, the cationic NIR-emitting cyanine dye 1,1′,3,3,3′,3′-hexamethylindotricarbocyanine 
(HMT) iodide. An example of an anion exchange reaction between HMT iodide and sodium bis 
(2-ethylhexyl) sulfosuccinate (AOT) is shown in Scheme 4.1. The various anions used in the 
formulation of our GUMBOS were selected for their varying hydrophobicities, geometries, and 
masses. All GUMBOS obtained were characterized by nuclear magnetic resonance (NMR) and 
elemental microanalysis and yielded results consistent with expectations.  
 As expected, the resulting NIR-emitting GUMBOS displayed variable physical 
properties (melting point, solubility) dependent upon variations in the anion (Table 4.1). This 
illustrates the tunability of our GUMBOS, allowing the design of a variety of physicochemical 
properties targeting select applications. In general, we found that the melting point decreased 
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with an increase in the size of the anion. For instance, HMT (Scheme 4.2) with a relatively 
smaller 4-(trifluoromethyl) phenyltrifluoroborate anion had a melting point of 98°C whereas the 
melting point decreased to 58°C when a larger AOT anion was used (Table 4.1). This 
observation is consistent with that of Larsen and coworkers who investigated the factors that 
affect melting point for imidazolium ILs.
30
 The authors concluded that the reduced crystal 
packing efficiency resulting from large anion incorporation played a profound role in depressing 
the melting point. Additionally, alkylation of the anion further frustrated the ion packing, causing 
a further drop in the melting point.
30
 It is worth noting that databanks and semi-empirical models 
to predict melting points of ILs have been published.
31
 References such as these serve as 
valuable resources when considering the design and synthesis of future GUMBOS.  
The solubility of ILs in water has been shown to be highly dependent on the choice of the 
anion.
32
 As expected, the miscibility of the various GUMBOS with water was also highly 
variable and dependent on the anion used in GUMBOS formation. The water-immiscible 
GUMBOS are suggestive of poor hydrogen bonding interactions, as exemplified by [HMT] 
[AOT]. However, some GUMBOS based on relatively hydrophilic iodide and boron-containing 
anions such as tetrafluoroborate showed enhanced aqueous solubility, possibly a consequence of 
the additional hydrogen bonding afforded by the degree of fluorination. In addition, the electron-
withdrawing properties of fluorine may induce dipole moments, resulting in dipole–induced 
dipole interactions with the surrounding water molecules.
33
 This postulate is supported by the 
 
Scheme 4.2. Structure of HMT NIR dye cation 
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Table 4.1. Melting points and aqueous solubilities of [HMT
+
]-derived GUMBOS with various 
anions.   
 

































aqueous solubility trend observed when comparing the mono- and di- trifluoromethyl substituted 
GUMBOS formed from 4-(trifluoromethyl) phenyltrifluoroborate and 3,5 bis (trifluoromethyl) 
phenyltrifluoroborate, respectively. In the latter case, the water immiscibility of HMT containing 
the 3,5 bis (trifluoromethyl) phenyltrifluoroborate anion may be attributed to a reduced net 
dipole moment arising from symmetric trifluoromethyl substitution.  
In each case, solutions of GUMBOS based on the [HMT
+
] cation were excellent absorbers of 
NIR irradiation. An example of this observation is shown in Figure 4.1A for a 1.0 µM ethanolic 
solution of [HMT][AOT] GUMBOS, where peak absorption occurs at 743 nm. As a result of the 
parent HMT cation, the GUMBOS fluoresce strongly in the NIR region, peaking near 765 nm; 
with the fluorescence excitation and emission spectra following the mirror-image rule (Figure 
4.1B) as expected from the Franck-Condon principle. As an example, the structure of the NIR 
emitting [HMT
+
] cation with bis (2-ethylhexyl) sulfosuccinate [AOT
–
] anion is shown at the top 
of Figure 4.1. Note that the focus in this chapter is on the spectral properties and cellular labeling 
using HMT AOT as model NIR nanoGUMBOS. Detailed investigation of the spectral properties 
of all the GUMBOS and nanoGUMBOS will be discussed in the next chapter. 
In the initial report on the preparation of nanoGUMBOS, we set forth a precedent for 
employing frozen ILs to manufacture size-controlled nanoparticles.
34
 In our earlier study, we 
developed a “melt-emulsion-quench” approach for the controllable formation of particles with 
average diameters spanning the 45 to 3000 nm range. In the current work, the preparation of 
nanoGUMBOS was achieved using a modified reprecipitation method,
35-39
 which is simpler to 
implement and more rapid. In a typical preparation, 100 µL of a 1 mM solution of GUMBOS 
precursor dissolved in ethanol was rapidly injected into 5 mL of triply-deionized water in an 
ultrasonic bath, followed by further sonication for 2 min. The ethanolic pre-GUMBOS solution  
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Figure 4.1. (A) Absorbance profile and (B) fluorescence excitation and emission spectra for 1.0 
µM [HMT][AOT] in ethanol; λex = 743 nm, λem = 765 nm. 
 
and water were both filtered prior to preparation of the nanoparticles using 0.2 µm nylon 
membrane filters. Post-preparation, the particle suspension was aged for 1 h in the dark. The 
average particle size and size distribution of the prepared nanoGUMBOS were obtained by use 
of transmission electron microscopy (TEM) and dynamic light scattering (DLS). We note that 
most of the water miscible solvents such as acetonitrile, tetrahydrofuran, dimethyl sulfoxide, N-
methyl pyrrolidinone, and acetone may be used in reprecipitation to obtain nanoGUMBOS 
dispersed in water. The reprecipitation synthetic method yields primarily spherical or slightly 
ovate nanoparticles as confirmed by TEM. A representative TEM micrograph of nanoGUMBOS 
with an average particle diameter of 79±18 nm is shown in Figure 4.2A. The polydispersity 
index obtained for these samples by use of DLS was generally quite good, usually under 0.100. 
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Figure 4.2. (A) TEM micrograph of [HMT][AOT] fluorescent NIR nanoGUMBOS with an 
average diameter near 79±18 nm; the inset shows a selected area electron diffraction pattern 
(SAED) for the [HMT][AOT] GUMBOS. (B) Absorbance spectrum of the [HMT][AOT] 
nanoparticles illustrated in panel A, and (C) comparison between the fluorescence emission 
spectrum of the freely dissolved [HMT][AOT] IL (1.0 µM in ethanol; red profile) and 
[HMT][AOT] nanoGUMBOS (blue profile) for matched absorptivity at the excitation 
wavelength (λex = 743 nm). 
 
The prepared NIR-emitting nanoGUMBOS displayed optical properties which were 
strikingly different from that of the initial ethanolic dye solution. The absorbance spectra for our 
nanoGUMBOS were generally broad and bimodal, extending to significantly lower wavelengths. 
For example, the absorbance of the [HMT][AOT] suspension was very broad, spanning from 
well below 600 nm to well over 800 nm (Figure 4.2B). When measured at an equivalent 
absorbance value, the emission intensity for the nanoparticle suspension was slightly lower and 
hypsochromically shifted by roughly 8 nm as compared to the parent compound dissolved in an 
EtOH solution (Figure 4.2C). This observation is highly characteristic of dye aggregation,
35, 40
 in 
this case reflecting intermolecular interactions between [HMT
+
] units. Decreased fluorescence 




 However, we can essentially rule out this possibility as powder X-ray 
diffraction measurements (data not shown) of the dried nanoGUMBOS reveal that the particles 
are in fact predominantly amorphous (see also the SAED pattern inset in Figure 4.2A).   
If the [HMT
+
]-derived nanoGUMBOS are dried and then redissolved in ethanol, they 
retain the spectral characteristics of the parent solution (Figure 4.3). This observation supports 
our contention that the remarkable variations in both absorbance and fluorescence properties 
wholly arise from the aggregation state of the [HMT
+
] within the nanoGUMBOS material. This 
also demonstrates that the intrinsic spectroscopic properties and chemical identity of the 
GUMBOS precursor („monomer‟ ion units)   
 
Figure 4.3. Normalized (A) absorbance and (B) fluorescence emission spectra of [HMT][AOT] 
(1.0 µM solution in EtOH; solid curve), and GUMBOS from Figure 4.2A redissolved in EtOH 
(dashed curve).  
 
remain unaltered during nanoparticle formation. This observation is important when considering 
the potential of GUMBOS for use as drug delivery and therapeutic vehicles. 
4.3.2. Cellular Uptake of NanoGUMBOS 
In order to demonstrate the potential of nanoGUMBOS as contrast agents for biomedical 
imaging applications, we examined cellular uptake and fluorescence images of these particles 
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using monkey kidney fibroblast (Vero) cells. Vero cells have previously been used for screening 
E. coli toxin and can serve as host cells for viruses as well as eukaryotic parasites. In the present 
study, Vero cells were used as model cells to investigate the cellular uptake of our 
nanoGUMBOS. Using an epifluorescence microscope, we captured fluorescence images 
revealing that [HMT][AOT] nanoGUMBOS can be internalized and subsequently visualized 
within viable Vero cells after 24 h of incubation (Figure 4.4).  These studies suggest the exciting 
potential of using nanoGUMBOS in cellular imaging. The apparent homogeneous fluorescence 
suggests that the nanoGUMBOS distribute nonspecifically inside the cells and are primarily 




Figure 4.4. Cellular uptake studies using a monkey kidney fibroblast (Vero) cell line. (A) A 
phase contrast micrograph and (B) the corresponding fluorescence image of Vero cells incubated 
for 24 h with 8.0 µg mL
–1
 [HMT][AOT] nanoGUMBOS. The fluorescence was collected using a 
propidium iodide (PI) filter set: λex = 540 nm; λem = 617 nm long pass. Scale bars in (A) and (B) 
are 10 µm. 
 
known adsorptive endocytosis process previously demonstrated for mesoporous silica 
nanoparticles;
41
 however, the exact cell-penetrating mechanism and localization of the 
nanoparticles is currently under investigation.   
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4.4. Conclusions 
In summary, we have synthesized and investigated preliminary spectral and cellular 
uptake properties of a novel series of NIR fluorescent nanoscale ionic materials we term 
nanoGUMBOS. By appropriate selection of a cationic NIR dye, these fluorescent nanoparticles 
were designed to exhibit absorbance and luminescent properties in the tissue-accessible NIR 
region of the electromagnetic spectrum. In this study, nanoGUMBOS 79±18 nm in diameter 
were fabricated by use of a simple, rapid, repeatable, and additive-free reprecipitation method 
requiring neither special nor costly laboratory apparatus. Beyond the ease of preparation, this 
work presents an entirely new direction for preparing contrast agent nanoparticles directly from 
tailored ionic materials. Our approach alleviates current problems associated with dye leakage 
and other challenges encountered in dye encapsulation, as well as obviating intensive 
purification steps required when surfactants are used to prepare dye nanoparticles. It is also 
noteworthy that the spectral properties of our GUMBOS deviate markedly from the freely 
dissolved dye present in solution. Thus, the possibility for tuning the optical properties of 
GUMBOS by variation in the parent ions offers a unique and exciting advantage for these 
nanomaterials. It was also demonstrated that these NIR fluorescent nanoparticles could be 
efficiently taken up in vitro by Vero cells, suggesting intriguing potential for non-invasive 
biomedical imaging. Even more exciting is the prospect of tailoring nanoGUMBOS for delivery 
into designated cellular structures. In any case, examination of the data presented for these 
cellular studies highlights a new potential for biomedical imaging using NIR fluorescent 
nanoGUMBOS.  
It should be possible to extend the findings from this investigation to fashion GUMBOS 
combining diverse functionalities (e.g., redox, superparamagnetic, luminescent, thermochromic, 
ligating) in order to arrive at truly multifunctional hybrid materials. One could easily envision 
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future polyfunctional nanoGUMBOS with applications including targeted diagnosis and therapy, 
photothermal cancer therapy, scintillators, radiosensitizers, biological separations, solar cells, 
and materials with defense applications (e.g., microwave-absorbers, security barcodes). The 
incorporation of high atomic number elements such as iodine or gold may enable their use as 
contrast agents for X-ray computed tomography (CT) scans. Likewise, GUMBOS carrying 
gadolinium chelates may open up potential for clinical diagnosis by use of magnetic resonance 
imaging (MRI).  
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In the process of exploring NIR nanoGUMBOS for biomedical imaging in the previous 
chapter, some striking observations were made in regard to the absorbance and fluorescence 
spectral properties of these NIR nanoGUMBOS. Conspicuous among these intriguing spectral 
properties is the broad absorption spectrum of the NIR nanoGUMBOS compared to the dilute 
GUMBOS solution. Such spectral differences have been associated with and may be due to 
formation of molecular self assemblies within the dye nanoparticles.
1
 This observation prompted 
the investigation undertaken in this chapter to characterize the type of aggregates that may be 
formed by the NIR fluorescent nanoGUMBOS as a function of varying the anion. To reiterate, 
GUMBOS are largely frozen ILs and some have melting points in excess of 100°C. It is 
therefore expected that the GUMBOS and the corresponding nanoGUMBOS will enjoy the 
unique properties of ILs such as negligible vapor pressure, high thermal stability and tunability.
2
 
In addition, the GUMBOS and nanoGUMBOS will exhibit their intrinsic properties suitable for 
various applications. 
As far as is known, there are two types of molecular dye aggregates namely, J and H-
aggregates. The J-aggregates (also known as Scheibe aggregates) were discovered independently 




 In this pioneering work, a high concentration of a 
pseudoisocyanine dye investigated exhibited a narrow red shifted absorption band compared to 
the monomer. In addition, the fluorescence emission had narrow band and small Stokes shift. 
Initially Scheibe postulated that this was due to reversible polymerization of chromophores.
4
 
This observation is now ascribed to strong coupling between transition dipole moments of the 




Conceptually, the molecules are arranged in a “brickwork” manner (head-to-tail 
arrangement) in J-aggregates whereas in H-aggregates, the molecules exhibit “card-pack” 
arrangement (face-to-face stacking).
7
 In general, the type of aggregate formed determines the 
type of transitions from the excitonic interactions between electronically coupled chromophores. 
Since their inception, considerable attention has been paid to molecular dye aggregates due to 







  In addition, the possibility of both H and J aggregates exhibiting 
superradiance, a phenomena resulting from cooperative emission has sparked tremendous 
interest in studies of molecular self assemblies.
15, 16
  
The aggregation phenomena has been well explained by the exciton theory illustrated by 
the energy level diagram (Figure 1.14).
17, 18
 In general, the type of aggregate formed determines 
the type of transitions from the excitonic interactions between electronically coupled 
chromophores. Large hypsochromic shift in absorption typical for dye H-aggregates is attributed 
to transition dipole interactions between two or more chromophores (H-aggregates) arranged 
parallel to each other with a small dislocation. The excited state is split into two components, due 
to the interaction of two transition dipoles. In this type of molecular assemblies, transition from 
ground state to higher energy state is allowed and hence the hypsochromic shift in absorbance 
and large Stokes shift in emission.
17
 In addition, fast internal conversion process from higher 
energy state to a non-emitting intermediate state leads to quenched emission in H-aggregates. In 
contrast, the allowed higher energy state in J-aggregates has a lower energy relative to the 
monomer leading to bathochromic shift in absorbance. In addition, there is no internal 
conversion to an intermediate non-emitting state and hence J-aggregates are highly fluorescent 




Several factors affect the type of aggregates formed including dye structure, dye 
concentration, solvent polarity, pH, ionic strength, and temperature.
19, 20
 It is worth noting that 
the properties of dye aggregates may also be influenced by interaction with biomolecules.
7
 For 
instance, such an interaction may enhance the low fluorescence quantum yield of H-aggregates 
while quenching the more fluorescent J-aggregates. The fluorescence enhancement phenomenon 
has been utilized by Gabor and coworkers for non-covalent labeling of the biomolecules. The 
ability to control the type of molecular aggregation for desired applications is one of the major 
challenges in the field of supramolecular chemistry. Supramolecular assemblies result from 
various non-covalent interactions such as electrostatic, hydrogen bonding, solvophobic and π-π 
stacking interactions. Several strategies have been employed to afford control of the type of 
aggregation. For instance, intramolecular heavy atom modification has been performed to 
prevent aggregation of a series of NIR tricarbocyanine dye commonly used as biological 
probes.
21
  The formation and spectral properties of dye aggregates have been controlled by use of 











Due to the aforementioned challenge of controlling the dye aggregation, organic 
fluorescent nanomaterials have recently attracted considerable interest because of the possibility 
of functionalization that may afford control of the resultant aggregates. Organic fluorescent 
nanomaterials have also found applications such as in OLEDs.
28, 29
 However, research on 
fluorescent organic nanoparticles is still in its infancy compared to their fluorescent inorganic 







, and optical sensors.
33
  
A number of reports on fluorescent organic nanoparticles mostly prepared using 
reprecipitation method have recently appeared.
22-26
 For example, Yao and coworkers have 




They observed a bathochromic shift in absorption transition and hypsochromic shift in emission 
of the nanoparticles with increasing size and attributed it to the restraint of vibronic relaxation 
and configurational reorganization.
34
 The organic molecules which are highly fluorescent in 
dilute solutions, mostly show significant quenching of fluorescence in the solid state due to 
increased intermolecular interactions.
28
 In addition to intermolecular interactions, such 
fluorescent switching in organic nanomaterials may also be due to conformation change or 
intramolecular planarization.  Several studies in the last few years reported the preparation of 
fluorescent dye nanoparticles and explained its fluorescent properties as an effect of J-
aggregation
35
 or sometimes absence of aggregation within the particle.
36
 As aforementioned, 
significant amount of work has been done in an attempt to control the aggregation behavior in 
dye assemblies in solutions, solid films, or nanoparticle templates. However, to our knowledge, 
there is no report on the control of aggregation within the dye nanoparticle itself. This study 
seeks to unveil a novel, simple method of controlling the aggregation within the NIR 
nanoGUMBOS by varying the anion. Considering that the H and J aggregates have interesting 
applications unique to their spectral properties, controlling the type of aggregation within the dye 
nanoparticle is highly desirable. The possibility of achieving such unprecedented controlled 
aggregation with the same chromophore may provide tremendous potential of a single dye being 
used in various applications; the exact reason for undertaking this study. The goal of this study is 
to explore this possibility by determining the changes in spectral properties and the aggregation 
behavior of fluorescent NIR GUMBOS and nanoGUMBOS as a function of varying the anion. 
5.2. Materials and Methods 
5.2.1. Materials 
1,1′,3,3,3′,3′-hexamethylindotricarbocyanine (HMT) iodide (97%), bis (2-ethylhexyl) 
sulfosuccinate (AOT) sodium salt (≥99%), lithium bis(trifluoromethane) sulfonimide, potassium 
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3,5 bis (trifluoromethyl) phenyltrifluoroborate, Sodium tetrakis[3,5-bis(1,1,1,3,3,3-hexafluoro-2-
methoxy-2-propyl)phenyl]borate, and ethanol (spectroscopic grade) were purchased from Sigma 
Aldrich and used as received. Lithium bis(pentafluoroethane) sulfonimide (LiBETI) was gladly 
donated by Gary Baker (Oakridge, TN). Triply deionized water (18.2 MΩ cm) from an Elga 
model PURELAB ultra
TM
 water filtration system was used for all preparations of NIR 
nanoGUMBOS. Carbon coated copper grids (CF400-Cu, Electron Microscopy Sciences, 
Hatfield, PA) were used for TEM imaging. 
5.2.2. Synthesis and Characterization of NIR GUMBOS and NanoGUMBOS 
The NIR GUMBOS (mostly ILs) were prepared using anion exchange procedures similar to 
those reported in the literature and as described in the previous chapter. The nanoGUMBOS 
were prepared from GUMBOS using a modified simple, additive-free reprecipitation method 
similar to that used for organic nanoparticles and explained in chapter 4 of this dissertation. 
Briefly, 100 µL of a 1 mM solution of GUMBOS precursor dissolved in ethanol was rapidly 
injected into 5 mL of triply-deionized water in an ultrasonic bath, followed by further sonication 
for 2 min. Post-preparation, the particle suspension was aged for 1 h in the dark.  
5.2.3. Characterization of NIR NanoGUMBOS 
The average particle size and size distribution of the prepared nanoGUMBOS were obtained by 
use of transmission electron microscopy (TEM) and dynamic light scattering (DLS). TEM 
micrographs were obtained using an LVEM5 transmission electron microscope (Delong 
America, Montreal, Canada). The NIR nanoGUMBOS dispersion (1 µL) was dropcasted onto a 
carbon coated copper grid and allowed to dry in air at room temperature before TEM imaging. 
X-ray diffraction measurements of dried nanoGUMBOS were obtained on a Nonius Kappa CCD 
diffractometer by long exposures with Mo Kα radiation and rotation of samples about the 
vertical axis.  
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5.2.4. Absorption and Fluorescence Studies of NIR GUMBOS and NanoGUMBOS 
Absorbance measurements were performed on a Shimadzu UV- 3101PC UV-Vis-near-IR 
scanning spectrometer (Shimadzu, Columbia, MD). Fluorescence studies were performed using a 
Spex Fluorolog-3 spectrofluorimeter (model FL3-22TAU3); Jobin Yvon, Edison, NJ). A 0.4 cm 
quartz cuvette (Starna Cells) was used to collect the fluorescence and absorbance against an 
identical cell filled with water as the blank. The absorption and emission spectra were 
deconvoluted using a Spec32 software based on principal component analysis and fits with 
chisquare values as low as the order of 10
-5
 were accepted. The absorption spectra were 
deconvoluted using a Gaussian fit and the emission spectra using a Lorentzian fit.  Both 
normalized and unnormalized spectra were deconvoluted using this software and it was observed 
that the ratio of all the three components in each spectrum remained the same in both the cases. 
The contribution from each component was calculated considering it to be proportional to the 
area under the corresponding component of the deconvoluted spectra. 
5.3. Results and Discussions 
5.3.1. Synthesis and Characterization of HMT NIR GUMBOS and NanoGUMBOS 
As explained earlier in the previous chapter, the resulting NIR-emitting GUMBOS 
displayed variable physical properties (melting point, solubility) dependent upon variations in the 
anion. This illustrates the tunability of our GUMBOS, allowing the design of a variety of 
physicochemical properties targeting select applications.  
The water insoluble GUMBOS were used to fabricate nanoGUMBOS dispersed in water, 
and a detailed investigation of their spectral properties as a function of varying the anion is 
investigated in this chapter of the dissertation. Once again, the structure of HMT cation used 





Scheme 5.1. Structure of HMT NIR dye cation 
 
Table 5.1. Chemical structures of the aqueous insoluble [HMT
+
]-derived GUMBOS with 
various anions used.   
 


















5.3.2. TEM Characterization of NanoGUMBOS 
TEM was performed as reported in the previous chapter. To reiterate, TEM 
characterization showed that the nanoGUMBOS are mainly spherical as further confirmed by 
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electron diffraction patterns. This suggests the amorphous nature of the nanoGUMBOS. Such 
amorphous character of nanoparticles has been reported to minimize quenching from internal 
conversion processes commonly observed in crystalline systems. This information is of 
significance to the study in this chapter because it prompted the investigation of the underlying 
factors that maybe influencing the spectral properties of nanoGUMBOS such as aggregation; 
which is the subject of this study. 
 
5.3.3. UV-visible Absorption Properties of HMT NanoGUMBOS 
The UV-visible absorption spectra of dilute ethanolic solutions of all the HMT GUMBOS 
with various anions are virtually overlapping (Fig 5.1). In addition, the maximum absorption is at 
the same wavelength (743 nm) as the ethanolic solution of [HMT][I] precursor. This indicates, 
HMT cation retain its intrinsic NIR optical properties after anion exchange to form HMT 
GUMBOS. In contrast, upon fabrication of nanoGUMBOS via reprecipitation in water, 
strikingly different absorption spectra were observed. In general, broad absorption spectrum was 
observed for all nanoGUMBOS but the spectral shape was unique for each nanoGUMBOS (Fig 
5.2). The broadening of the absorption spectra extended to both longer and shorter wavelength 
regions compared to the monomeric dilute HMT GUMBOS solution. Specifically for 
[HMT][AOT], [HMT][NTF2] and [HMT][3,5-(CF3)2PhBF3 nanoGUMBOS, the spectra seems to 
develop absorption shoulders in both the red and blue region with respect to the absorbance of 
the monomer. The broadness of the absorption band is considered to be either due to 
superposition of the absorption bands of preoriented molecules around 735 nm and the formed 
aggregates or due to the oscillation or rotation of the aggregates beyond the resolution of the 
spectrometer.  
A better insight into the intriguing absorption spectra of the nanoGUMBOS was gained 
by deconvolution of the spectra using software based on principal component analysis.
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Figure 5.1. Absorption spectra of dilute ethanolic solutions (1 µM) of HMT GUMBOS   
 
 


























Figure 5.2. Absorption spectra of HMT nanoGUMBOS 
 124 
Interestingly, the resolved absorption spectra reveal that each absorption spectrum is 
composed of three bands which maybe assigned to three different types of absorbing species 
(Fig. 5.3). The component absorbing near 735 nm is assigned to those aggregates in the 
nanoGUMBOS whose transition dipoles are randomly oriented and are expected to absorb in the 
monomer region (recall that the dilute ethanolic solutions of HMT GUMBOS absorbance peaks 
near this wavelength). The bathochromically shifted component absorbing near 753-783 nm is 
assigned to the J-type of aggregates in which the transition dipoles are arranged in a head-to–tail 
manner. On the other hand, the hypsochromically shifted absorbance in the range 580-672 nm 
maybe assigned to the H-type of aggregates in which the transition dipoles tends to align parallel 
to each other.  
It can be deduced from the deconvoluted absorption spectra (Figure 5.3), that H-type, J-type and 
randomly oriented aggregates were formed in relatively different proportions. This may explain 
the differences in broad shapes of the absorption bands for different nanoGUMBOS as a function 
of varying the anion. It is observed that in [HMT][AOT], [HMT][NTF2] and [HMT][3,5-
CF3PhBF3] nanoGUMBOS, the J-component predominates over the H-component (Figure 5.3). 
In contrast, the H-components are predominant in HMTBETI and [HMT][(OCH3(CF3)2)2Ph4B] 
nanoGUMBOS (Figure 5.3). It is also observed that among the three dyes with predominant J-
aggregates the contribution of the randomly oriented species is maximum for [HMT][3,5-(CF3)2 
PhBF3] followed by [HMT][AOT] and [HMT][NTF2]. These J/H ratios and contributions from 
the randomly oriented species play a profound role in influencing the fluorescence emission 
properties of the nanoGUMBOS. 
5.3.4. Fluorescence Emission Properties of HMT NanoGUMBOS 
Steady state fluorescence results were complementary to absorption studies (both 
resolved and non-resolved spectra). All HMT GUMBOS ethanolic dilute solutions displayed 
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Figure 5.3. Resolved absorption spectra of HMT (A) AOT (B) NTf2 (C) 3, 5-CF3 (D) BETI (E) 
OCH3 nanoGUMBOS 
 
comparable fluorescence intensities with emission maxima at 765 nm (Figure 5.4A). 
Surprisingly, the nanoGUMBOS dispersed in water had variable emission properties based on 
the anion used in the GUMBOS. Specifically, the [HMT][AOT] and [HMT][3,5-CF3PhBF3] 
nanoGUMBOS were found to be the most fluorescent (Figure  5.4B). This was followed by 
[HMT][NTF2] nanoGUMBOS with modest fluorescence emission intensity (Figure 5.4B). 
However, the [HMT][BETI] nanoGUMBOS were weakly fluorescent and 
[HMT][(OCH3(CF3)2)2Ph4]B nanoGUMBOS being virtually non-fluorescent (Figure 5.4B). 
Approximately 10 nm blue shift in the emission maxima of the nanoGUMBOS compared to that 
of ethanolic solution is probably due to the negative solvatochromic effect. 
Considering the three species of the resolved absorption spectra, the major contribution to 
fluorescence emission comes from the randomly oriented component
 
and the J-component. Thus 
though the HMT NTF2 nanoGUMBOS has higher J/H ratio compared to HMT 3,5-CF3PhBF3 
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(Figure 5.5), the latter has relatively better fluorescence yield due to the highest contribution 
from the randomly oriented component (Figure 5.6). It is therefore not surprising that HMT AOT 
 
 
Figure 5.4. Fluorescence emission properties of HMT (A) GUMBOS (1 µM ethanolic solution) 
and (B) nanoGUMBOS 






































































nanoGUMBOS with the highest J/H ratio and significant contribution of randomly oriented 
species (Figure 5.5 and 5.6) is the most fluorescent in the series. The weak fluorescence behavior 
of HMT BETI may be due to the lower J/H ratio (<1) and higher contribution from H-type of 
aggregates. Whereas the lowest J/H (<1) ratio and the highest contribution from H-component of 
the HMT [OCH3(CF3)22Ph]4B nanoGUMBOS (Figure 5.5) may account for the extremely 
quenched fluorescence emission.   
The emission spectra of the nanoGUMBOS were also deconvoluted and three different 
emitting species were observed for HMT AOT and HMT NTf2 as representative nanoGUMBOS 
(Fig 5.7). The emission near 750 nm is assigned to the randomly oriented component. The two 
emission peaks near 760 and 780 nm are probably due to the fluorescence of two different types 









Figure 5.6. Mole fraction of the randomnly oriented components of HMT nanoGUMBOS 
 
Fig. 5.7. Representative resolved emission spectra of nanoGUMBOS (A) HMTAOT (B) HMT 
NTf2 
 
It is interesting to note that [HMT][AOT] and [HMT][3,5-(CF3)PhBF3] nanoGUMBOS 




The fluorescence of [HMT][NTF2] nanoparticles are slightly less than the corresponding 
ethanolic solutions while that of [HMT][BETI] and [HMT][(OCH3(CF3)2)2Ph)4B] are highly 
quenched compared to the corresponding ethanolic solution. This variation in fluorescence yield 
of the nanoGUMBOS maybe explained by the type of preferred relative orientation of the 
individual dye molecules in the nanoparticle. Consistent with this explanation, the more J-
aggregating HMT nanoGUMBOS have greater fluorescence yield and the vice versa is true for 
the predominantly H-aggregating nanoGUMBOS having the least fluorescence yield (Figures 5.4 
and 5.5).  
It can be inferred from these spectral properties that within the nanoGUMBOS of 
HMTAOT, [HMT][NTF2] and [HMT][3,5-CF3PhBF3], head-to-tail type of arrangements are 
thermodynamically more favored compared to stacking imparting highly fluorescent properties 
to the nanoGUMBOS. In contrast, molecular stacking maybe more favored in [HMT][BETI] and 
[HMT][(OCH3(CF3)2)2Ph4B], making these nanoGUMBOS weakly fluorescent to virtually non-
fluorescent. It has been reported that cyanine dyes with longer polymethine chain are more H-
aggregating in solution. Despite having a long polymethine chain, the spectral properties of 
HMT cationic cyanine dye used in this study suggest that J-aggregation likely occurs depending 
on the anion used. 
In general, solubility of ILs in water has been shown to be dependent on the anion.
37
 
Hydrophobic anions such as BETI and NTF2 enhance the formation of hydrophobic GUMBOS.
38
 




 We note that 
the presence of fluorines have been reported to induce some hydrophilic properties.
39
 This 
suggests that hydrophobicity may not be influenced solely by the length of the alkyl chain. 
Therefore, in addition to structural factors which might determine the type of aggregation within 
the nanoGUMBOS, the extent of hydrophobicities of the anions can be roughly correlated to the 
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preferred orientation of the transition dipoles within the nanoparticles. The experimental results 
from this study suggest that a higher degree of hydrophobicity of an anion within a given family 
might induce a preferred stacking of the transition dipoles forming more H-type of aggregates. 
5.3.5. Fluorescence Anisotropy Studies of HMT GUMBOS and NanoGUMBOS 
In fluorescence anisotropy the rotational diffusion of a molecule is related to its size and 
shape. It is a useful technique to measure the binding interaction between two molecules since 
bound molecules rotate slowly resulting in higher anisotropy.
40, 41
 Fluorescence anisotropy is 
calculated using the formula: r = (Ivv-GIvh)/(Ivv+2GIvh); where G is the grating factor that has 
been included to correct the wavelength response for polarization response of the emission optic 
and the detector. Ivv and Ivh are the fluorescence intensity measured parallel and perpendicular to 
the vertically polarized excitation, respectively.
40, 41
 
  Fluorescence emission anisotropy studies were performed for both dilute HMT 
GUMBOS ethanolic solutions as well as the nanoGUMBOS exciting at 737 nm. These 
measurements reveal that the dilute ethanolic solutions of all the HMT GUMBOS have 
significantly low anisotropies lying between 0.01-0.02 (Table 5.2). The anion has no significant 
effect on the anisotropy in dilute solutions. All the HMT nanoGUMBOS possess higher 
anisotropies than their corresponding dilute GUMBOS solutions (Table 5.2) and exhibit 
fluorescence emission anisotropy spectra with different features for the different anions.  
The [HMT][AOT] and [HMT][NTF2] which were found to be more J-aggregating 
possess a low anisotropy value over the entire emission wavelength with an intense band near 
775nm (Figure 5.8) which is approximately the absorption wavelength of the J-aggregates for 
these nanoparticles as observed in the deconvoluted spectra. Thus it can be stated that the main 
emitting species in these two cases are the J-aggregates having resonance fluorescence 
properties. While for [HMT][3,5-(CF3)2PhBF3] the fluorescence anisotropy spectra exhibits a 
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minima near 750 nm (Figure 5.8) revealing the fact that in this case the main emitting species is 
the randomly oriented component which emits near the monomer region along with its J-
aggregate which absorbs and emits near 754 nm as seen in the resolved spectra. As mentioned 
earlier, J-aggregates are characterized by resonance fluorescence. But the value of anisotropy of 
the particle is much greater than that of the corresponding monomer in dilute solutions 
suggesting that the emitting species is within the particle and not in solution. This fact also 
supports our deconvoluted data which shows maximum randomly oriented component for this 
GUMBOS anion pair in which the J-aggregate absorbs near 754 nm. Fluorescence anisotropy 
values of HMT BETI nanoparticles are much higher over the entire emission range with two 
intense bands near 770 nm and 810 nm respectively (Figure 5.8) suggesting the presence of two 
significantly different types of aggregates.   
The fact that the fluorescence anisotropy of the dye aggregates in the nanoGUMBOS is 
higher than the corresponding dilute dye solutions suggests that the rotational diffusion of the 
dye within the nanoGUMBOS are much slower. Furthermore, negligible amount of energy is lost 
through energy migration within the dye aggregates in the nanoGUMBOS. Another observation 
that the NIR nanoGUMBOS with higher J/H ratio has lower values of emission anisotropy might 
suggest that the rotational diffusion of the dye within the J-type of aggregates is faster compared 
to that in randomly oriented or H-type of aggregates.  
 It is well established that anisotropy depends on the direction of transition moments.
40, 41
 
In case of dye aggregates the transition dipoles are oriented in a definite manner and hence the 
response to parallel and perpendicularly polarized light is quite distinct in the emission spectra.
40, 
41
 In this study, it was observed that a significant difference exists between the intensities of 
perpendicular and parallel polarized emission for those HMT dye anion pairs in which the 
transition dipoles are mostly oriented in head to tail manner i.e. forming J-type of aggregates. In 
 132 
addition, difference between the two emission intensities decreases with the decreasing J-
component. For example, [HMT][AOT] and [HMT][NTF2] has maximum difference between Ivv 
and Ivh suggesting that these nanoGUMBOS contain maximum amount of J-aggregates (Figure 
5.8). From the resolved absorption and emission spectra of [HMT] [3,5-(CF3)2PhBF3], the J-
component is comparatively lower. Consequently, the difference between Ivv and Ivh decreases 
which is further diminished in predominantly H-aggregating HMT BETI nanoGUMBOS. 
 


































Figure 5.8. Fluorescence emission anisotropy of (A) HMT AOT and (B) HMT NTF2 


































Table 5.2. Steady state anisotropy values of various HMT GUMBOS 1 µM ethanolic solution 










 750 nm 775 nm 750 nm 775 nm 
HMT AOT  0.0215  0.02196  0.0435  0.0344  
HMT35(CF3)PheB  0.01858  0.01904  0.08265  0.09846  
HMT NTf2  0.01922  0.01723  0.04052  0.0365  
HMT BETI  0.01103  0.01257  0.15809  0.14442  
 
 5.4. Conclusions 
In summary, we have successfully presented a novel idea of controlling the type of 
aggregation within the NIR nanoGUMBOS by retaining the same dye skeleton and simply 
varying the anion. Though the various dye anion pairs have similar spectral properties in solution 
phase, the nanoGUMBOS display intriguingly different properties as a function of varying the 
anion. This tunable spectral behavior in the nanoGUMBOS is mainly attributed to the difference 
in the arrangement of individual transition dipoles within the particles. The findings from this 
study suggest that more hydrophobic anions may preferably induce H-aggregation in the 
nanoGUMBOS. In contrast, J-aggregation may be preferred with less hydrophobic anions. It is 
also possible that this observation may be dependent on the structure of the dye being 
investigated. 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 
In addition to designing CILs for enantiomeric recognition, the work presented in this 
dissertation is part of the effort to develop new nanomaterials from a new class of compounds 
termed Group of Uniform Materials Based on Organic Salts (GUMBOS). The first part involves 
the use of CILs that are liquid at room temperature (RTILs) for enantiomeric recognition of 
various chiral analytes using fluorescence spectroscopy. The second part of this dissertation 
mainly explores novel NIR fluorescent nanoGUMBOS as contrast agents for biomedical imaging 
and investigates the tunability of the spectral properties of the nanoGUMBOS as a function of 
varying the anion.  
The first chapter provides a synopsis of the topics related to the work presented in this 
dissertation such as ILs, CILs, chirality, NIR GUMBOS and nanoGUMBOS. The synthesis, 
characterization and applications of CILs and nanoGUMBOS is described. In chapter 2, the 
synthesis of a series of CILs in both enantiomeric forms form alanine tert-butyl ester chloride is 
described. The alanine tert-butyl ester bis (trifluoromethane) sulfonylimide was obtained as 
liquid at room temperature with high thermal stability. Both enantiomeric forms of alanine tert-
butyl ester bis (trifluoromethane) sulfonylimide could be used as solvent and chiral selector for 
enantiomeric recognition of various fluorescent analytes, alleviating the need for use of 
environmentally damaging solvents to dissolve the analyte.  
In Chapter 3, the work in chapter 2 is extended to include enantiomeric recognition of 
analytes with reduced fluorescence by developing CILs from intrinsically fluorescent amino 
acids. The synthesis, characterization and investigation of the enantiomeric recognition 
properties of a fluorescent CIL, L-phenylalanine ethyl ester bis (trifluoromethane) sulfonimide 
(L-PheC2NTf2) is reported for the first time. Such a CIL is advantageous over previously 
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reported non-fluorescent CILs, whose applications were limited to the use of less sensitive 
modes of detection such as absorption, or to the use of fluorescence in discrimination of a small 
subset of intrinsically fluorescent analytes.  
The results of an effort towards development of new nanomaterials in our research group 
is presented in chapter 4 with the evaluation of novel NIR nanoGUMBOS derived form a 
cationic NIR dye for biomedical imaging applications. It was also demonstrated that these NIR 
fluorescent nanoGUMBOS could be efficiently taken up in vitro by Vero cells, suggesting an 
interesting potential for non-invasive biomedical imaging applications. The nanoGUMBOS were 
fabricated by use of a simple, rapid and additive-free reprecipitation method. Considering the 
ease of preparation, this work presents an entirely new direction for preparing contrast agent 
nanoGUMBOS directly from tailored ionic materials. The approach described alleviates current 
problems associated with dye leakage and other challenges encountered in dye encapsulation, as 
well as obviating intensive purification steps required when surfactants are used to prepare dye 
nanoparticles. We note that the spectral properties of our GUMBOS were strikingly different 
from the freely dissolved dye present in solution. Thus, the possibility for tuning the optical 
properties of GUMBOS by variation in the parent ions offers a unique and exciting advantage for 
these nanomaterials. Since the NIR fluorescent nanoGUMBOS could be efficiently taken up in 
vitro by Vero cells, the prospect of tailoring nanoGUMBOS for delivery into designated cellular 
structures is an exciting new research possibility. In addition, this work could easily be extended 
to include GUMBOS with more than one property. For instance, incorporating a magnetic anion 
with the NIR nanoGUMBOS provides fluorescent and magnetic bimodal imaging modes.  
Chapter 5 seeks answers to the intriguing observations made on the spectral properties of 
the NIR nanoGUMBOS upon variation of the anion. These NIR nanoGUMBOS described in 
chapter 4 displayed broad absorption spectra and the fluorescence emission of the 
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nanoGUMBOS was blue shifted compared to the dilute solution of the monomeric dye. These 
observations have been previously attributed to molecular aggregation and efforts to explain and 
control this phenomenon are detailed in the dissertation. The findings from this study suggest 
that both H and J aggregation occur at relatively different proportions depending on the anion. 
As far as is known, the most interesting part of our study is the unprecedented possibility of 
controlling the type of aggregation within the NIR nanoGUMBOS by retaining the same dye 
cationic skeleton and simply varying the counterion. In future, the possibility of preparing NIR 
nanoGUMBOS system containing both H and J aggregates exhibiting superradiance (a 
phenomena resulting from cooperative emission) will be of tremendous interest. In addition to 
varying the anion, the design of cation/ anion combination or conditions that can exclusively 
achieve the desired aggregate (H or J) for specific applications will be a useful study. Further, it 
is interesting that J aggregates derived from non-chiral molecules have been noted to be CD 
active due to the helical arrangement of J aggregates. This is another possible investigation on 
the NIR nanoGUMBOS to distinguish the various aggregates since the H aggregates and 
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